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Abstract 
 
Reactive oxygen species (ROS) have been implicated in T-cell 
hyporesponsiveness, apoptosis, as well as activation and differentiation. However, 
the majority of the published studies have been performed using the Jurkat leukemic 
T-cell line or preactivated T cells (T-cell blasts). Moreover, in many cases, non-
physiological stimuli or exogenously applied H2O2 were employed to induce or to 
mimic ROS production in T cells, respectively. On the other hand, very few studies 
have analyzed the role of TCR-triggered ROS under more physiological conditions, 
for example using human peripheral blood T cells isolated from healthy donors 
(primary T cells). Therefore, in order to shed light onto the function of ROS in primary 
T cells, I have analyzed which reactive oxygen species are produced upon T-cell 
stimulation, where ROS are produced, and their function in T-cell activation. 
First, I have shown that, upon TCR ligation, T cells produce superoxide that is 
released into the extracellular space. Nevertheless, it appears that this reactive 
species is not required for T-cell functions. Indeed, treatment of cell cultures with 
antioxidants, such as superoxide dismutase and ascorbate, which remove 
extracellular superoxide, does not affect activation, proliferation, and cytokine 
production of CD3xCD28-stimulated primary human T cells. It has been reported that 
T cells can produce superoxide via the NADPH oxidase 2 (NOX-2). To more 
specifically analyze the function of superoxide, I have used NOX-2-deficient mice 
(gp91phox -/-). I have found that T cells from these mice completely lack inducible TCR-
mediated superoxide production but display normal upregulation of activation 
markers and proliferation. Collectively, I have shown that primary T cells produce 
extracellular superoxide upon TCR triggering via NOX-2, but that this reactive 
species is not required for T-cell activation, proliferation, and cytokine production. 
In the second part of my work, I have investigated whether mitochondria-
derived ROS participate in T-cell activation. By using various mitochondrial inhibitors, 
I have found that mitochondrial membrane potential, but not mitochondria-derived 
ROS or ATP, is crucial for the activation of primary human T cells. 
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1 Introduction 
1.1 The immune system 
 
One of the inherent properties of any living system is the dynamical 
maintenance of its structure, despite the harsh impact of the environment and errors 
in the system itself. In order to achieve this goal, a living system must possess 
mechanisms to discriminate between “correct” and “incorrect” structures. In 
multicellular organisms, such a mechanism is called immunity, or immune system. 
The natural constituents of the body, which are normally not subject to attack by 
components of the immune system, are called self. On the contrary, the foreign 
material that enters the body (such as viruses, bacteria or parasites) and the altered 
structures of the body (such as mutated or malignant cells), which normally stimulate 
an attack by the immune system, are called non-self. Either self or non-self structures 
that actually do evoke an immune response and that are capable of binding with a 
product (such as an antibody) of the immune response are called antigens. 
Self and non-self can differ so slightly that the immune system must be 
extremely sensitive to discriminate between them (1). The lack of sensitivity leads to 
various immune deficiencies, such as recurring infections and cancer. On the other 
hand, extreme sensitivity necessitates extreme specificity, otherwise many false 
alarms would be triggered (2, 3). Autoimmune diseases are an example of specificity 
problems, and originate from erroneous recognition of self as non-self.  
Achieving high sensitivity and specificity is a difficult, time- and resource-
consuming process, and is mediated by the adaptive branch of the immune system 
(also referred to as acquired or specific). Only vertebrates possess this kind of 
immunity. The cells that mediate adaptive immunity are T and B lymphocytes. While 
B cells produce antibodies, T cells destroy infected or malignant cells and help to 
coordinate the immune response. A more basic component of immunity is the innate 
(or non-specific) immune system, which is present in all multicellular organisms, 
including plants and fungi (Fig. 1.1). Besides enhanced specificity and delayed 
response, the main property of the adaptive immune system that differentiates it from 
the innate one is the immunological memory. This allows faster recognition and 
elimination of reoccurring antigens.  
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Figure 1.1 Innate and adaptive immunity 
The innate immune system functions as the first line of defense against 
infection. It consists of soluble factors, such as complement proteins, and 
diverse cellular components, including granulocytes (basophils, eosinophils, 
and neutrophils), mast cells, macrophages, dendritic cells, and natural killer 
cells. The adaptive immune response is slower to develop, but it possesses 
high antigenic specificity and memory. It consists of antibodies, B cells, and 
CD4+ and CD8+ T lymphocytes. Natural killer T cells and γδ T cells are 
lymphocytes that bridge the innate and adaptive immunity. Adopted from (4). 
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1.2 T lymphocytes 
 
1.2.1 T-cell development 
 
“T” in T lymphocytes stands for “thymus-derived”, because these cells mature in 
the thymus. Hematopoietic stem cells in bone marrow differentiate into lymphoid 
progenitor cells that migrate to the thymus, where they become double-negative (DN) 
thymocytes, named after the absence of CD4 and CD8 expression (Fig. 1.2). At the 
DN stage, thymocytes express a unique β-chain of the T-cell receptor (TCR), which 
is generated upon recombination of V(D)J gene fragments. The expression of a 
functional TCRβ-chain together with an invariant pre-Tα-chain allows developmental 
progression (beta selection). Once past this step, DN thymocytes rearrange the TCR 
α-chain through recombination of VJ gene fragments (5). In parallel, DN cells 
upregulate the expression of CD4 and CD8, thus becoming double-positive (DP) 
thymocytes. If DP thymocytes express a non-functional TCR, they die by apoptosis 
(death by neglect) (Fig. 1.2). Conversely, if DP thymocytes express a functional TCR, 
which is capable of interacting with self-antigens presented via major 
histocompatibility complexes (MHCs) I or II, which are expressed on the surface of 
cortical thymic epithelial cells (cTECs), they survive (positive selection), migrate to 
the medulla, and develop as either CD4+ or CD8+ (also referred to as single-positive, 
SP) cells (6) (Fig. 1.2).  
As I mentioned above, successful immune response requires not only high 
sensitivity but also high specificity. To minimize the risk of developing autoreactive T 
cells, thymocytes undergo negative selection. This process ensures that thymocytes 
whose TCRs are capable of strong binding to self-peptides presented on the MHC 
complexes of cTECs or medullary TECs (mTECs) are eliminated via apoptosis (7, 8) 
(Fig. 1.2). The process by which newly developing lymphocytes are rendered non-
reactive to self is called central tolerance. It is worth noting that central tolerance is 
not 100% efficient, and some autoreactive T cells escape thymic selection. Additional 
mechanisms of peripheral tolerance exist to silence these cells. They include the 
suppression of autoreactive cells by regulatory T (Treg) cells, the generation of 
hyporesponsiveness (anergy) in lymphocytes that encounter antigen in the absence 
of co-stimulatory signals, and the existence of immunologically-privileged areas (9). 
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Figure 1.2 T-cell development in the thymus 
Hematopoietic stem cells (HSC) in the bone marrow differentiate into lymphoid 
progenitor cells (LP) that migrate to the thymus, where they become double-
negative thymocytes (DN). DNs either successfully rearrange the β-chain of T-
cell receptor (TCRβ) or undergo apoptosis. Next, DNs rearrange the TCR α-
chain and upregulate CD4 and CD8, thus becoming double-positive 
thymocytes (DP). If DPs express non-functional TCRs, they die by apoptosis 
(death by neglect). Conversely, if DPs express TCRs capable of interacting 
with self-antigens presented by cortical thymic epithelial cells (cTECs), they 
survive (positive selection), migrate to the medulla, and develop as either 
CD4+ or CD8+ (single positive thymocyte, SP) (lineage commitment). 
Thymocytes whose TCRs are capable of strong binding with self-antigens 
presented by cTECs or medullary TECs (mTECs) are eliminated via apoptosis 
(negative selection). Positively selected cells exit the thymus as naïve (Tnai) or 
regulatory (Treg) T cells. Green bubbling cells indicate apoptosis.  
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1.2.2 T-cell subsets 
 
T cells represent a heterogeneous population that consists of several subsets. 
As I mentioned above, two major T-cell subsets are generated in the thymus - CD4+ 
T cells and CD8+ T cells.  
CD4+ T cells are also called helper T (Th) cells. They are activated by peptide 
antigens in complex with MHC II, expressed on the surface of antigen-presenting 
cells (APCs). Dendritic cells, macrophages, and B cells can act as APCs. Upon 
activation, Th cells proliferate and secrete cytokines. Depending on the profile of 
secreted cytokines, Th cells are further divided into minor subsets (10) (Fig. 1.3). Th1 
cells secrete IFNγ, IL-2, and Lymphotoxin alpha (LT-α). These cytokines activate 
macrophages and CD8+ cells. Th1 cells promote cell-mediated immunity against 
tumor cells and intracellular pathogens, such as viruses. Th2 cells secrete IL-4, IL-5, 
IL-10, and IL-13. These cytokines activate B cells, as well as eosinophils, basophils 
and mast cells. Th2 cells promote antibody-mediated immune responses and host 
defense against extracellular parasites. 
In recent years, additional Th subsets were identified (11). Th9 cells secrete IL-9 
and IL-10 and are involved in host defense against extracellular parasites, especially 
nematodes. Th17 cells secrete IL-17a, IL-17f, IL-21, IL-22, IL-26, and Chemokine (C-
C motif) Ligand 20 (CCL-20). These cytokines activate neutrophils, as well as B cells. 
Th17 cells promote protective immunity against extracellular bacteria and fungi, 
mainly at mucosal surfaces. Follicular helper T cells (Tfh) secrete IL-4 and IL-21. 
These cytokines activate follicular B cells. Tfh cells are involved in promotion of 
germinal center responses.  
Overall, different subsets of Th cells orchestrate different branches of the 
immune response. However, it has also become evident that Th cells can convert 
from one subset to another and even express mixed cytokine profiles (12, 13) (Fig. 
1.3). This plasticity enables quicker and more precise responses to pathogenic 
threats. 
CD8+ T cells are also known as cytotoxic T (Tc) cells. They can be activated by 
peptide antigens in complex with MHC I, expressed on the surface of any nucleated 
cell. These antigens are usually derived from intracellular pathogens, such as 
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viruses, or from mutated proteins of tumor cells. Upon activation, Tc cells proliferate, 
with the help of IL-2 from Th cells, and release cytotoxic proteins, such as perforin, 
granzymes, and granulysin. Perforin makes pores in the plasma membrane, thus 
allowing serine proteases granzymes to enter the cell and trigger apoptosis (14). On 
the other hand, granulysin forms pores in the cell wall of intracellular pathogens, 
which, in turn, allows granzymes to enter and kill them (15). Alternatively, Tc can 
induce apoptosis via the interaction between Fas ligand on their surface and Fas 
receptor on the target cell (16). 
Treg cells, formerly known as suppressor T cells, are crucial for the maintenance 
of peripheral tolerance (17). Their major role is to suppress the activation of 
autoreactive T cells that escaped negative selection in the thymus. Additionally, Treg 
cells shut down conventional T-cell activity, thus contributing to the termination of the 
immune response. Treg cells are either directly generated in the thymus from CD4+ 
thymocytes, referred to as natural Treg cells, or originate from activated CD4+ T cells 
in the periphery, referred to as induced Treg cells (18). The various potential 
suppression mechanisms used by Treg cells can be grouped into four basic modes of 
action (19): (i) release of inhibitory cytokines (TGFβ, IL-10, and IL-35) or IL-2 
deprivation; (ii) granzyme- and perforin-dependent cytolysis; (iii) cAMP- and 
adenosine-dependent metabolic disruption; (iv) LAG-3- and CTLA-4-dependent 
suppression of dendritic cell maturation or function. 
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Figure 1.3 CD4+ T-cell subsets 
Naive T cells can differentiate into various Th subsets upon priming in 
response to different cytokines. These helper T-cell subsets express lineage-
defining transcription factors that induce specific surface markers in the steady 
state and release characteristic effector cytokines following TCR stimulation. 
Adopted from (10). 
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1.2.3 T-cell activation 
 
T cells that exit the thymus are called naïve (Tnai) because, unlike effector (Teff) 
or memory (Tmem) T cells, they have not encountered their specific (cognate) antigens 
yet or, in other words, they have not yet been activated. Tnai cells are characterized 
by the surface expression of CD127 (IL-7Rα), CD62L (L-selectin), CD197 
(Chemokine (C-C motif) Receptor (CCR-7)), and RA isoform of CD45 (Protein 
Tyrosine Phosphatase, Receptor type, C (PTPRC)). Tnai cells are quiescent and non-
dividing but require periodic contacts with self-peptide-MHC and IL-7 for homeostatic 
survival (20, 21). L-selectin and CCR-7 lead to the localization (homing) of Tnai cells 
to secondary lymphoid organs, such as lymph nodes (22, 23). There, they 
continuously scan APCs for the presence of cognate antigens. When the TCR on the 
surface of Tnai cell recognizes a cognate antigen in complex with MHC-II molecules 
on the surface of APC, Tnai cell becomes activated (see next section). Costimulation 
via CD28 and/or other surface molecules is necessary for successful activation, 
otherwise T cells become anergic (24). This is a mechanism to reduce the risk of 
autoimmunity. 
Proper T-cell activation results in the up-regulation of the surface markers CD25 
(IL-2Rα), CD44 (Homing Cell Adhesion Molecule (HCAM)), and CD69 (C-Type 
lectin). Activated T cells secrete IL-2, intensively proliferate, and differentiate into 
various Teff and Tmem subsets (25-28). Activated CD4+ T cells generate Th and/or Treg 
progenitors, whereas activated CD8+ T cells are precursors for Tc cells. Teff change 
the CD45 isoform from RA to RO, lose IL-7 receptor CD127 and lymphoid tissue 
homing receptors CD62L and CD197, and populate the periphery, to fight infection or 
cancer in situ. After the pathogen or tumor have been cleared, expanded Teff cells die 
via Fas-mediated apoptosis (activation-induced cell death, AICD) or cytokine 
depletion-induced apoptosis (death by neglect), during so-called contraction phase of 
the immune response (29). This limits excessive consumption of nutrients, damage to 
the body, and development of autoimmunity. Tmem cells are preserved in the body 
much longer than Teff cells. At the second encounter with pathogen, they can initiate 
a faster and stronger immune response (30). Tmem cells are classically distinguished 
by the expression of the CD45RO isoform, CD44, CD127, and CD215 (IL-15Rα), and 
require IL-7 and IL-15 for homeostatic survival (20).  
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1.2.4 T-cell signaling 
 
The TCR consists of one α- and one β-chain, linked by disulfide bond. Both 
chains include variable, constant, transmembrane, and cytoplasmic regions. The 
variable parts are generated through genetic recombination during thymic 
development and are required for the recognition of antigens (31). They are unique 
for each T-cell clone. The other parts are necessary for anchoring of the TCR to the 
plasma membrane and for the association with accessory molecules, such as CD3 
and ζ-chain, to form the TCR/CD3 complex. The TCR/CD3 complex consists of a 
TCRαβ heterodimer, CD3εδ and CD3εγ heterodimers, and a ζζ-chain homodimer 
(32) (Fig.1.4 A). 
The TCR complex does not possess catalytic activity and is dependent on Non-
receptor Lymphocyte-specific protein tyrosine Kinase (LCK) to initiate downstream 
signaling cascade. LCK associates with CD4 and CD8 co-receptors that interact with 
MHC, and therefore is brought into close proximity of the TCR upon T cell-APC 
interaction. The main function of LCK is to phosphorylate the Immunoreceptor 
Tyrosine-based Activation Motifs (ITAMs) on CD3 and ζ chains of TCR complex (33) 
(Fig.1.4 A). 
LCK activity is regulated mainly via two tyrosine residues, Tyr505 in the C-
terminus and Tyr394 in the catalytic domain (33, 34) (Fig.1.4 B). Phosphorylation of 
LCK on Tyr505 by C-terminal Src Kinase (CSK) results in the binding of the C-
terminus to the SH2 domain of LCK, producing the closed, inactive conformation. 
Tyr505 can be dephosphorylated by Protein Tyrosine Phosphatase, Receptor type, C 
(PTPRC, CD45), leading to the primed form. Primed LCK can autophosphorylate or 
phosphorylate other primed nearby LCK molecules on Tyr394, resulting in the open, 
active conformation, that is capable of phosphorylating ITAMs and Zeta-chain-
Associated Protein kinase of 70 kDa (ZAP-70). Tyr394 can be dephosphorylated by 
Protein Tyrosine Phosphatase, Non-receptor type, 22 (PTPN-22), SHP-1 (SH2 
domain-containing Phosphatase 1), or CD45, thus converting LCK back to the 
primed state. Moreover, open LCK can be further phosphorylated by CSK on Tyr505 
without losing its catalytic activity. ZAP-70 binds to phosphorylated ITAMs via SH2 
domains but remains autoinhibited due to the interaction between Tyr319 and the 
catalytic domain. LCK phosphorylation of ZAP-70 at Tyr319 relieves the autoinhibited 
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conformation, leading to ZAP-70 activation via trans-autophosphorylation of Tyr493 
(33, 34).  
Activated ZAP-70 phosphorylates nine tyrosine residues in the Linker for 
Activation of T cells (LAT). After that, the intracellular domain of LAT becomes able to 
organize the assembly of a multiprotein complex called the LAT signalosome. The 
LAT signalosome recruits both positive and negative regulators of T-cell signaling 
and initiates multiple signaling cascades and feedback loops (35) (Fig. 1.5). 
Ultimately, this culminates in the activation of three major T-cell transcription factors – 
Nuclear Factor of Activated T cells (NFAT), Nuclear Factor kappa light chain 
enhancer of activated B cells (NFkB), and Activator Protein 1 (AP-1). These factors 
initiate the expression of various genes coding for surface receptors, such as CD69 
and CD25, and for growth-promoting cytokines, such as IL-2 (36). 
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Figure 1.4 TCR structure and LCK regulation 
(A) TCR interacts with an antigenic peptide–MHC complex, and the co-receptor 
(CD4 or CD8) brings LCK in the proximity of the TCR/CD3 complex. LCK can 
then phosphorylate the CD3-associated ITAMs. Adopted from (37). 
(B) Primed LCK can be either phosphorylated on Tyr505 by CSK, resulting in the 
binding of Tyr505 to the SH2 domain and thus producing the closed, inactive 
conformation, or can auto- or trans-autophosphorylate on Tyr394, resulting in 
the open, active conformation. Moreover, open LCK can be further 
phosphorylated by CSK on Tyr505 without losing its catalytic activity (not 
shown). Tyr505 can be dephosphorylated by CD45. Tyr394 can be 
dephosphorylated by CD45, SHP-1, or PTPN-22. Modified from (38). 
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Figure 1.5 TCR signaling pathways 
LCK is recruited to the TCR/CD3 complex by CD4 (or CD8) and 
phosphorylates ITAMs and phospho-ITAM-bound ZAP-70. Activated ZAP-70 
phosphorylates LAT, leading to recruitment of SLP-76 (SH2 domain-
containing Leukocyte Protein of 76 kDa), ITK (IL-2-inducible T-cell Kinase), 
and PLCγ-1 (Phospholipase C γ 1). LCK then phosphorylates ITK, which, in 
turn, phosphorylates PLCγ-1. Activated PLCγ-1 converts PIP2 
(phosphatidylinositol 4,5-bisphosphate) into IP3 (inositol-1,4,5-trisphosphate) 
and DAG (diacylglycerol). IP3 engages specific receptors at the intracellular 
calcium store, leading to store depletion. This triggers opening of CRAC 
(Calcium-Release Activated Channels) at the plasma membrane and 
sustained calcium influx. The resulting rise in intracellular calcium is sensed 
by calcineurin, which dephosphorylates NFAT, leading to its translocation to 
the nucleus. DAG activates PKCθ (Protein Kinase C θ) and RASGRP (RAS 
Guanyl-Releasing Protein). This results in the activation of mitogen-activated 
protein kinases, such as JNK (C-Jun N-terminal Kinase) and ERK 
(Extracellular-signal-Regulated Kinase), leading to the activation of AP-1. In 
addition to DAG, PKCθ and ERK pathways can be activated through RAC 
(RAS-related C3 botulinum toxin substrate) and SOS (Son of Sevenless), 
respectively. PKCθ also activates NFkB. Additional proteins and pathways are 
involved in cell adhesion and migration. Adopted from (39) 
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1.3 Reactive oxygen species (ROS) 
 
1.3.1 ROS as harmful by-products of metabolism 
 
ROS are small short-lived oxygen-containing molecules that are chemically 
highly reactive, a property that is mainly due to their unpaired electrons (radicals). 
Superoxide (O2•−), hydrogen peroxide (H2O2), hydroxyl radical (OH•), hypochlorous 
acid (HOCl), lipid peroxides (ROOH), singlet oxygen (1O2), and ozone (O3) are some 
of the most common ROS (40). The first two species are the most important ROS in 
the regulation of biological processes. Superoxide is usually the species from which 
other ROS originate (Fig. 1.6). Once produced, and if it does not rapidly react with 
surrounding molecules, superoxide dismutates to H2O2, spontaneously or with the 
help of superoxide dismutase (SOD) (41). Hydrogen peroxide is more stable, less 
reactive, can diffuse in the microenvironment, and even cross cell membranes. H2O2 
can either react with particular amino acids, usually cysteines and methionines, or 
can be converted to OH• (in the Fenton reaction), to HOCl (by myeloperoxidase), or 
to H2O (with the help of catalase, peroxidase, or peroxiredoxin) (42) (Fig. 1.6). Both 
the OH• and HOCl are highly reactive and usually irreversibly damage nearby 
molecules. 
One of the major sources of ROS in the cell are mitochondria (43, 44) (Fig. 1.6). 
Mitochondria express the electron transport chain (ETC) complexes, which transfer 
electrons from reduced Nicotinamide Adenine Dinucleotide (NADH) and succinate, 
along a controlled redox pathway, to oxygen molecule (O2). Upon receiving four 
electrons, oxygen is reduced to H2O. However, the ETC is not perfect, and 
occasionally O2 undergoes one- or two-electron reduction to form O2•− or H2O2, 
respectively. Complexes I and III of the ETC are the main sources of mitochondrial 
O2•− (43, 44). Multiple metabolic enzymes, such as Endoplasmic Reticulum 
Oxidoreductin 1 (ERO-1), cytochromes P-450 and b5, lipoxygenases, 
cyclooxygenases, α-ketoglutarate- and glycerol phosphate dehydrogenases, as well 
as hydroxyacid-, urate-, xanthine-, monoamine-, diamine-, polyamine-, and amino 
acid oxidases, are also producing ROS as necessary intermediates or byproducts of 
their reactions (45). They can be found in mitochondria, endoplasmic reticulum, 
peroxisomes, and cytosol. Moreover, a class of membrane-bound NADPH oxidases 
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produces ROS for antimicrobial and signaling purposes (see next section). Finally, 
there are exogenous sources of ROS, including ultraviolet and gamma radiation, 
smoke and other air pollutants, several drugs and chemicals, which are usually 
harmful for the cell. 
As ROS can damage proteins, lipids, and nucleic acids, the evolution has 
created specialized antioxidant systems. They consist of antioxidant enzymes, such 
as SODs, catalases, glutathione peroxidases (GPXs), peroxiredoxins (PRXs), 
thioredoxins (TRXs), glutaredoxins (GRXs), sulfiredoxins (SRXs), thioredoxin 
reductases, glutathione reductases, and methionine sulfoxide reductases (46), and 
also small non-enzymatic antioxidant molecules, such as glutathione, ascorbate, 
pyruvate, α-ketoglutarate, and oxaloacetate (47). When the rate of ROS production in 
the cell significantly exceeds the rate of their neutralization by the antioxidant 
systems, cell undergoes oxidative stress. Prolonged or excessive oxidative stress 
can lead to impairment of cellular functions, cell death, senescence, or malignant 
transformation (48-50). 
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Figure 1.6 Reactive oxygen species, their sources, and scavengers 
Superoxide (O2•−) can be produced by the mitochondrial electron transport 
chain (Mito-ETC) upon one-electron reduction of oxygen (O2), by NADPH 
oxidase (NOX) at the plasma membrane, by enzymes at the endoplasmic 
reticulum (ER), or by cytoplasmic metabolic enzymes (ME). O2•− then 
dismutates to hydrogen peroxide (H2O2), either spontaneously or with the help 
of superoxide dismutases (SOD). H2O2 can be neutralized by catalase or by 
glutathione peroxidase (GPX), using oxidation of glutathione (GSHr to GSSG). 
Glutathione is reduced by glutathione reductase (GR), using oxidation of 
NADPH. H2O2 can participate in the Fenton reaction (Fe2+) and be converted 
to hydroxyl radical (HO•). Modified from (51). 
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1.3.2 ROS as weapons of phagocytes 
 
Phagocytic cells produce ROS as a strategy to kill engulfed bacteria during the 
so-called respiratory burst (52). In these cells, ROS are produced by the Phagocytic 
NADPH Oxidase (PHOX), an enzyme consisting of several subunits (53) (Fig. 1.7 B). 
The catalytic subunit, called PHOX glycoprotein of 91 kDa (gp91phox) or NADPH 
oxidase 2 (NOX-2), is located at either the plasma membrane or the phagosome 
membrane. PHOX includes also a variety of regulatory subunits: a membrane-
anchored p22phox and cytoplasmic p40phox, p47phox, and p67phox, as well as the RAC 
GTPase. PHOX becomes functional upon assembly of this multisubunit complex, a 
process that is under tight regulation.  
The respiratory burst can be triggered by a large and diverse group of agonists. 
They include phagocytosable particles (e.g., bacteria, yeast), antibodies, 
complement, interleukins, chemotactic peptides, and bioactive lipids. The kinetics 
and overall level of O2•− production in response to different agonists varies widely 
(54). Activated PHOX transfers electrons across the membrane from NADPH to O2, 
generating O2•−. Superoxide can directly damage bacteria, can react with other 
antimicrobial molecules, or can dismutate to hydrogen peroxide. H2O2, in turn, can 
react with metal ions, leading to production of highly poisonous OH•, or can be 
converted to even more toxic HOCl by myeloperoxidase, an enzyme which is 
abundant in the azurophil granules of neutrophils (55). PHOX-derived ROS have also 
been suggested to increase the pH of phagosomes, thus supporting the activity of 
neutral proteases (56, 57). The importance of PHOX in the immune response has 
been demonstrated by the fact that patients with mutations in this enzyme suffer from 
chronic granulomatous disease, a clinical condition characterized by recurring 
bacterial and fungal infections (58). 
Interestingly, six homologs of gp91phox (NOX-2) have been identified in different 
tissues: NOX-1, NOX-3, NOX-4, NOX-5, Dual Oxidase 1 (DUOX-1), and DUOX-2 
(59, 60) (Fig. 1.7). As mentioned above, NOXs are usually activated upon triggering 
of cell receptors by their respective ligands, such as insulin, angiotensin, Platelet-
Derived Growth Factor (PDGF), Granulocyte–Macrophage Colony-Stimulating Factor 
(GM-CSF), Fibroblast Growth Factor (FGF), Nerve Growth Factor (NGF), TNF, 
chemokines that bind G protein-coupled receptors, complement component 5a 
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(C5a), sphingosine-1-phosphate (S1P), lysophospholipids (LPLs), and leukotriene B4 
(LB4), as well as by cell adhesion and by phagocytosis (47). Because of the 
widespread yet differential expression of NOX and DUOX isoforms across 
organelles, cell types, and organisms, O2•− and H2O2 can be potentially considered as 
ubiquitous chemical signaling messengers. 
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Figure 1.7 Subunit composition, activation, and cellular distribution of 
NADPH oxidases 
(A) NOX-1 activity requires p22phox, NOX Organizer 1 (NOXO-1), NOX Activator 1 
(NOXA-1), and RAC. It is expressed in colon epithelial cells. 
(B) NOX-2 requires p22phox, p47phox, p67phox, and RAC. p47phox phosphorylation is 
required for NOX-2 activation. p40phox also associates with this complex and 
may contribute to activation. It is expressed in phagocytes and lymphocytes. 
(C) NOX-3 requires p22phox and NOXO-1. The requirement for NOXA-1 and RAC 
in its activation is under debate. It is expressed in cochlear and vestibular 
sensory epithelial cells. 
(D) NOX-4 requires p22phox and appears to be constitutively active. It is expressed 
in smooth muscle and endothelial cells of kidney and blood vessels. 
(E) NOX-5 is activated by Ca2+ through EF-hands and does not appear to require 
subunits. It is expressed in splenic and lymph node lymphocytes and in 
spermatocytes. 
(F) DUOX-1/2 are activated by Ca2+ through EF-hands and do not appear to 
require subunits. They also possess peroxidase-like ectodomains. They are 
expressed in thyroid epithelial cells. 
 
Adopted from (60).  
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1.3.3 ROS as ubiquitous signaling messengers 
 
During the last decade, it has become evident that ROS are not just harmful 
byproducts of metabolism and weapons of phagocytes, but that they also play crucial 
roles in cellular signaling. ROS-mediated signaling is involved in multiple processes, 
such as cell growth (59, 60), stem cell renewal (61, 62), tumorigenesis (47, 59, 62), 
cell death (59, 60), cell senescence (60, 62), cell migration (61), oxygen sensing (60), 
angiogenesis (60), circadian rhythm maintenance (61), and immune responses (47, 
60).   
Among ROS, hydrogen peroxide acts as the major signaling messenger and is 
excellently suited for this function (63). In fact, it is stable enough, is able to cross cell 
membranes, and is reacting preferentially with cysteine residues (42). It has to be 
noted that cysteine residues are amongst the most conserved and least abundant 
protein residues (64), which ensures high selectivity and specificity for oxidation-
mediated post-translational modifications. Moreover, only specific cysteinyl thiols (R-
SH) that can become thiolate anions (R-S-), upon coordination with neighboring 
amino acid side chains, are able to react with H2O2 (65).  
When H2O2 reacts with a cysteine thiolate anion, a sulfenic acid (R-SOH) is 
formed (66, 67). This process, which is referred to as sulfenylation, is reversed by 
GRXs and TRXs (46, 65) (Fig. 1.8). Thus, sulfenylation is believed to be akin to 
phosphorylation or other post-translational modifications. Sulfenylation may lead to 
further post-translational modification, such as glutathionylation and disulfide bond 
formation (66, 67). Most importantly, it can be involved in the regulation of protein 
activity. In fact, sulfenylation can induce changes in protein conformation, thus 
leading to activation or inactivation of the catalytic center or to other functional 
alterations of the protein. Multiple protein classes have been shown to be regulated 
by sulfenylation, including phosphatases and kinases, transcription factors and 
histone deacetylases, antioxidant enzymes and heat-shock proteins, proteases and 
hydrolases, ion channels and pumps, adaptor molecules and cytoskeleton 
components (47, 61, 62, 66-68). 
In the presence of high levels of ROS, sulfenic acid can be further oxidized to 
sulfinic (R-SO2H) and then to sulfonic (R-SO3H) acid, the latter being a completely 
irreversible modification, whereas the former could be reversed by SRXs (66, 67) 
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(Fig. 1.8). In addition to cysteine, H2O2 can also react with methionine, another sulfur-
containing amino acid, albeit with a four-fold lower rate. The resulting modification 
can be reversed by methionine sulfoxide reductase (66). Thus, an additional 
methionine-based signaling system has been proposed (69). Moreover, various ROS 
can react with other amino acid residues or protein cofactors (such as [Fe-S] 
clusters), causing irreversible modifications. Their role in signaling is less defined (47, 
61, 68). 
Interestingly, in addition to modifying transcription factors, ROS can react 
directly with DNA. This reaction is believed to activate transcription (47). For 
example, ROS produced by hypoxic mitochondria oxidize specific bases in the 
promoter of Vascular Endothelial Growth Factor (VEGF). This event enhances the 
binding of Hypoxia-Inducible Factor 1 alpha (HIF-1α) transcription factor to the VEGF 
promoter (70). 
It is believed that NOX enzymes are the major source of “signaling” ROS (71). 
Nevertheless, it is likely that ROS produced by the mitochondrial ETC or metabolic 
enzymes are also involved in signaling processes (72-75). The levels of ROS that are 
involved in signal transduction are much lower than the levels occurring during 
respiratory burst or oxidative stress. Moreover, due to the abundance of antioxidant 
systems in the cell, ROS cannot travel long distances, and hence they transmit 
signals only locally, in confined compartments (76, 77). In other words, the source 
and the corresponding targets of signaling ROS usually have to be in close proximity.  
ROS-mediated signaling can be additionally regulated via controlled alterations 
in the local levels and activity of specific antioxidants (61, 68). For example, 
intracellular glutathione is a good scavenger for many ROS, such as HOCl, but 
reacts too slowly with H2O2, the major mediator of oxidative signaling. On the 
contrary, PRXs have remarkably high reaction rates with H2O2, and their activity is 
tightly regulated by phosphorylation and sulfinilation. PRXs appear to be the major 
scavengers of “signaling” ROS, akin to phosphatases in the kinase-phosphatase 
system, and thus constitute a crucial component of redox signaling (46, 61, 68, 78-
81). Moreover, the members of the aquaglyceroporin and aquaporin families can 
enhance the permeability of cell membranes to H2O2, thus adding an additional level 
of regulation to ROS-mediated signaling (61) (Fig. 1.8). 
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Figure 1.8 Signal transduction by ROS and peroxiredoxins 
 
The binding of the ligand to its cognate receptor leads to the activation of 
several downstream signaling events. One pathway involves sequential 
activation of Phosphatidylinositol-3-Kinases (PI3K) and RAC, leading to the 
assembly and activation of NOX. After activation, NOX produces extracellular 
O2•− that spontaneously dismutates to H2O2. Small amounts of H2O2 diffuse 
into the cell through lipid bilayer, but much more can enter through 
aquaporins. Once inside the cell, H2O2 alters the activity of redox-sensitive 
targets by oxidizing specific reactive cysteine residues (-SH) into sulfenic acid. 
This modification is reversed by TRXs and GRXs (the latter is not depicted in 
the figure). Another pathway leads to the activation of Sarcoma protein family 
(SRC) members, which phosphorylate PRXs, thus inactivating them. 
Inactivated PRXs can be dephosphorylated by tyrosine phosphatases (PTPs). 
Active PRXs keep H2O2 concentrations low by neutralizing it with their 
cysteinyl thiols. PRXs are reduced back by TRXs and GRXs (not depicted in 
the figure). However, high concentrations of H2O2, produced, for example, 
upon NOX activation, lead to overoxidation of PRX cysteine residues into 
sulfinic acid. This modification can be slowly reverted by SRXs. Such temporal 
inactivation of PRXs by NOX-derived H2O2 allows prolonged sulfenylation of 
target proteins and transduction of the oxidative signal (the “floodgate” model). 
Modified from (62). 
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1.4 ROS and T cells 
 
The complex role of ROS in T-cell biology can be simplified by dividing it into 
two parts: (i) the effects (usually detrimental) of large exogenous quantities of ROS 
on the overall redox state and function of T cells, known as “oxidative stress”, and (ii) 
the function of small amount of compartmentalized endogenous ROS in T-cell 
signaling (hereafter referred to as “signaling ROS”). The latter can be implicated in 
both activation and apoptosis of T cells (82). 
 
1.4.1 Oxidative stress and T cells 
 
T cells are often present in close proximity to phagocytic cells, which are known 
to produce large amounts of ROS. Moreover, activated T cells can trigger phagocytic 
respiratory burst by direct cell-cell contact (83), as well as by secreted cytokines. The 
produced ROS can, in turn, reach T cells and cause oxidative stress (Fig. 1.9). For 
example, it has been shown that f-MLP (N-Formyl-Methionyl-Leucyl-Phenylalanine)-
activated neutrophils inhibit CD3-mediated DNA synthesis in human T cells and that 
this inhibition of T-cell proliferation is proportional to superoxide levels (measured by 
cytochrome c reduction) (84). More importantly, treatment with the glutathione 
precursor N-acetyl cysteine (NAC) or catalase prevents this inhibition (84). Further 
analysis showed that the inhibition of DNA synthesis is associated with alterations of 
TCR signaling, such as conformational changes in TCRζ and LCK, reduced PLCγ-1 
phosphorylation and calcium flux, and increased ERK phosphorylation (84). 
Nevertheless, this study shows that activated neutrophils do not induce apoptosis in 
T cells. An additional study attempted to mimic the effects of phagocyte-derived ROS 
by treating human T cells with polyamine oxidase-generated H2O2 for a prolonged 
time (85). This treatment suppresses CD3-induced tyrosine phosphorylation and IL-2 
production, PHA (Phytohaemagglutinin)-induced calcium flux, and PHAxTPA 
(Tetradecanoylphorbol acetate)-induced NFAT and NFkB (but not AP-1) activation 
(85). Thus, it can be concluded from these studies that phagocyte-derived ROS 
inhibit T-cell signaling, activation, and proliferation, without affecting T-cell survival. 
Many investigators have also induced oxidative stress by short-term treatment 
with high levels (in the millimolar range) of exogenous H2O2. Instead of suppression, 
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which is induced by the prolonged action of intermediate levels of ROS produced by 
phagocytes (~10 nmol O2-/min per 106 cells (54)), this strong and transient treatment 
with H2O2 has the opposite effect on T cells. Indeed, high amounts (≥5 mM) of H2O2 
induce tyrosine phosphorylation of multiple molecules and calcium flux in the Jurkat 
T-cell line even in the absence of other stimulatory agents (86). Among the 
phosphorylated proteins, important signaling molecules, including SLP-76 (87), LCK 
(88, 89), ZAP-70 (86), and ERK (87), were found to be activated by high ROS levels. 
Interestingly, the tyrosine phosphorylation of SLP-76 and the activation of ERK in 
response to H2O2 (ranging from 1 to 10 mM) is absent in the ZAP-70-deficient Jurkat 
T-cell variant (P116) (87). ERK activation is rescued by reconstituting P116 with ZAP-
70, indicating that H2O2 acts at the level of ZAP-70 or upstream (87). High H2O2 
levels (ranging from 1 to 5 mM) also induce strong tyrosine phosphorylation in 
preactivated human T cells (T-cell blasts) (90). Unfortunately, because the high levels 
of ROS used in these studies are far above the physiological concentrations, it is 
hard to interpret these data with regard to the function of ROS in T cells. 
Phagocytic cells regulate the redox state of the microenvironment not only by 
releasing ROS, but also by producing antioxidants, especially the glutathione 
precursor cysteine (Fig. 1.9). LPS (Lipopolysaccharide)- or TNF-activated murine 
macrophages secrete cysteine that can be taken up by T cells, thus resulting in an 
increased intracellular glutathione level (91). Human dendritic cells also secrete 
cysteine, as well as TRX, upon co-incubation with alloreactive human T cells (92) 
(Fig. 1.9). Coculture of antigen-pulsed human dendritic cells (but not B cells) with 
autologous T cells leads to an increase in the content of both cell-surface and 
intracellular thiols in antigen-specific (but not in antigen-non-specific) T cells and 
protects them from H2O2-induced apoptosis (93). LPS stimulation or direct contact of 
DCs with murine T cells leads to release of cysteine by dendritic cells, its subsequent 
uptake by T cells, and conversion to glutathione (94). This correlates with the 
acquisition of a reduced state by T-cell surface thiols (94). On the other hand, Tregs 
suppress cysteine release by DCs, thus leading to the oxidation of surface thiols, 
decrease in intracellular glutathione, and reduction in DNA synthesis, in conventional 
T cells (94). It has been proposed that this represents a novel mechanisms used by 
Tregs to suppress the activation of peripheral T cells. Additional experiments showed 
that murine Tregs suppress glutathione synthesis and cysteine release by dendritic 
cells, in a Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA-4)-dependent manner 
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(95) (Fig. 1.9). The addition of exogenous cysteine partially reverts Treg-induced 
inhibition of DNA synthesis in CD3- or peptide-activated T cells (95). In contrast to 
conventional human T cells, Tregs have higher thiol content (but expressed similar 
levels of catalase, Manganese SOD (MnSOD, SOD-2), and Copper-Zinc SOD 
(CuZnSOD, SOD-1)), and are more resistant to cell death induced by granulocyte-
secreted H2O2 (96). Moreover, human Tregs express and secrete more TRX-1 than 
conventional T cells, and upregulate it stronger upon CD2xCD3xCD28 stimulation 
(97). Thus, activated phagocytes and dendritic cells secrete cysteine to the 
extracellular space, which is taken up by T cells and converted to the antioxidant 
glutathione. Regulatory T cells interfere with this process and, by doing so, inhibit T-
cell activation. 
Glutathione seems to be indispensable for T-cell proliferation. It is required for 
protein and DNA synthesis in IL-2-dependent murine T-cell clones (98), (91), for 
ConA (Concanavalin A)-induced DNA synthesis in murine T cells (99), and for 
CD2xCD3-, CD3xPMA (Phorbol 12-myristate 13-acetate)-, or diC8 (1,2-
Dioctanoylglycerol)xIono (Ionomycin)-induced DNA synthesis in human T cells (100, 
101). Glutathione is also required for proper LAT conformation in human T cells 
(102), for localization of LAT to the plasma membrane in Jurkat T cells (102), and for 
CD3-induced calcium flux in Jurkat T cells (103). These findings suggest that 
sufficient levels of this antioxidant are required to maintain a proper redox balance, 
which, in turn, appears to be indispensable for T-cell signaling and proliferation. It is 
also possible that T-cell proliferation depends on some redox-unrelated functions of 
glutathione.  
Overall, under physiological conditions there is likely an equilibrium between 
ROS and antioxidant systems, thus allowing normal T-cell function (Fig. 1.9). 
However, perturbation of such equilibrium by ROS overproduction or by depletion of 
antioxidants can lead to T-cell hyporesponsiveness or hyperactivation, thus resulting 
in the development of pathological conditions.  
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Figure 1.9 Regulation of the T-cell redox state 
 
Activated phagocytes produce H2O2 via NOX. H2O2 either oxidizes thiols (SH-) 
on the surface of T cells or enters inside T cells. Intracellularly, H2O2 either 
oxidizes glutathione (GSH) or interferes with DNA synthesis. Activated 
phagocytes and dendritic cells (DC) secrete cysteine (Cys) to the extracellular 
space. Cys is taken up by T cells and converted to GSH. GSH keeps surface 
thiols in a reduced state, neutralizes intracellular H2O2, and is required for 
DNA synthesis. TCR-peptide-MHC interaction leads to the secretion of TRX 
by T cells, DCs, and Treg cells. TRX helps to keep surface thiols in a reduced 
state. Treg cells inhibit Cys release by DCs via CTLA-4/B7 interaction. Black 
solid arrow indicates production, black dashed arrows indicate import/export, 
green solid arrows indicate activation, red bar-headed lines indicate inhibition. 
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1.4.2 ROS and T-cell apoptosis 
 
Stimulation of activated T cells – T-cell blasts, as well as Jurkat T cells or other 
T-cell lines, results in activation-induced cell death (AICD) (29). In this section, I 
summarize the data describing the function of ROS in Jurkat T cells and T-cell blasts 
(see also Table 1). While the majority of the data on ROS function during AICD have 
been generated using Jurkat T cells, the results obtained from a transformed cell line 
should be interpreted with caution. In fact, it is known that Jurkat T cells have 
mutations in important genes involved in TCR signaling (104).  
Jurkat T cells exhibit oxidation of the superoxide-sensitive dye luminol upon 
PMA stimulation (105). In addition to PMA, luminol oxidation is induced by ConA, 
PHA (105), and ligation of the death receptor Fas (106). PMA or PHA stimulation of 
Jurkat T cells leads also to the oxidation of the ROS-sensitive dye 2',7'-
Dichlorofluorescein diacetate (DCFDA) (107, 108). Analysis of the molecular 
mechanisms regulating ROS production showed that PMAxIono and CD3 
stimulations induce DCFDA oxidation that is dependent on RAS signaling, in 
particular on the RAS-like GTPase (RAL), and could be inhibited by RAS-related 
protein 1 (RAP-1) (109). Studies from another group showed that PMAxIono- and 
CD3-induced DCFDA oxidation, FasL upregulation, and cell death are dependent on 
PKCθ and mitochondrial complex I (108, 110) (Fig. 1.10). CD3-induced (but not 
PMA-induced) DCFDA oxidation is also dependent on ZAP-70, LAT, SLP-76, and 
PLCγ-1 (110). In other studies, it has been shown that CD3 stimulation induces two 
waves of DCFDA oxidation that depend on DUOX-1, as well as a wave of oxidation 
of the superoxide-sensitive dye Dihydroethidium (DHE) (111, 112). The first wave of 
DCFDA oxidation appears to be also dependent on LCK, ZAP-70, SLP-76, PLCγ-1, 
IP3 receptor, and intracellular (but not extracellular) calcium (112) (Fig. 1.10). 
CD3xCD28 stimulation also induces oxidation of the H2O2-sensitive mitochondria-
targeted dye Dihydrorhodamine 123 (DHR) (113). Additionally, triggering of Fas 
increases DHE but, surprisingly, decreases DCFDA oxidation (114). Moreover, FasL 
induces oxidation of DHE, DHR, and HO-sensitive dye 3”-(p-hydroxyphenyl) 
fluorescein (HPF) (115). Thus, triggering of the TCR or Fas in Jurkat T cells leads to 
ROS production from various sources, such as DUOX-1 and mitochondria, via the 
activation of different signaling cascades (Fig. 1.10). 
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While the Jurkat T-cell line was used in the studies described above, other 
studies have employed human and murine T-cell blasts. CD3 stimulation of murine T-
cell blasts induces Fas-dependent DCFDA oxidation by NOX-2-derived ROS (116) 
(Fig. 1.10). Moreover, CD3 stimulation also induces transient DCFDA oxidation that 
is not dependent on Fas or NOX-2 and Fas-dependent DHE oxidation that is not 
mediated by NOX-2 (116), indicating that at least two more sources of ROS are 
involved in AICD. CD3 stimulation of human T-cell blasts triggers MEK-dependent 
oxidation of DHE and DCFDA (111, 117). Other studies have shown that CD3 
stimulation of human T-cell blasts leads to DHE and DCFDA oxidation, FasL 
expression, and cell death that all depend on mitochondrial complex I (108, 110, 
118). Thus, in T-cell blasts, ligation of the TCR or Fas leads to ROS production via 
NOX-2, mitochondria, and potentially other sources. 
Different groups have studied the role of ROS in T-cell signaling and apoptosis 
using RNA interference and knockout mice. It has been shown that CD3-induced 
MEK and ERK activation are enhanced, whereas AKT activation is suppressed, in T-
cell blasts from gp91phox-/- mice (116) (Fig. 1.10). However, it appears that apoptosis 
of murine T-cell blasts in response to CD3 stimulation is not dependent on gp91phox 
(119). Suppression of DUOX-1 with shRNA in Jurkat T cells leads to decreases in 
calcium flux, in LCK, ZAP-70, and ERK phosphorylation, as well as in AP-1 and 
NFAT activation, upon CD3 stimulation (112). Similarly, suppression of DUOX1 with 
siRNA in human CD4+ T-cell blasts leads to decreases in CD3-induced ZAP-70, 
PLCγ-1, and ERK phosphorylation, PLCγ-1, SHP-2, and GRB-2-Associated Binding 
protein 2 (GAB-2) association with GRB-2, as well as in SHP-2 oxidation and 
association with GAB-2 (112) (Fig. 1.10). Thus, both NOX-2 and DUOX-1-derived 
ROS are involved in TCR-mediated signaling in T-cell blasts and Jurkat T cells. 
In order to investigate the role of ROS in T-cell signaling and apoptosis, other 
groups have used micromolar doses of H2O2. The majority of studies have been 
performed in the Jurkat T-cell line. It has been shown that the addition of 30-50 μM 
H2O2 enhances CD3xCD28-induced p38, JNK, and ERK activation (120, 121). 
Moreover, 200 μM H2O2 induces MEK-dependent ERK activation, as well as SRC- 
and calcium-dependent Ribosomal S6 Kinase (RSK) activation (122). Similarly, 100-
1000 μM H2O2 induces MEK and ERK activation, in a PLCγ-1- and calcium-
dependent manner (121). In addition, 400 μM H2O2 induces p38, JNK, and ERK 
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activation in a SRC-dependent manner and inhibits the phosphatase activities of 
CD45, SHP-1, and Hematopoiesis-speciﬁc Protein Tyrosine Phosphatase (HePTP) 
(123). Interestingly, induction of ERK activation by H2O2 is dependent on PLCγ-1 and 
PKC, whereas induction of p38 and JNK activation is not (123). 50-500 μM H2O2 
induces NFkB and AP-1 (c-Jun) (but not NFAT) activation (124-126). Moreover, 
same concentrations suppress NFAT activation upon PHAxPMA-stimulation (126). 
Interestingly, 100 μM H2O2 enhances PDBU (phorbol dibutyrate)- or TNF-induced 
activation of NFkB when added simultaneously, but suppresses it when added 20 or 
3 hours before stimulation (127). 50-200 μM H2O2 induces calcium flux (125). Thus, 
applications of exogenous H2O2 in micromolar range to Jurkat T cells induce calcium 
flux and the activation of several signaling molecules (including p38, JNK, MEK, 
ERK, PLCγ-1, PKC, and LCK) and transcription factors (including NFkB and AP-1). 
Conversely, they suppress CD45, SHP-1, HePTP, and NFAT activation. 
It has been additionally shown that exogenous H2O2 may induce apoptosis in 
Jurkat T cells. In fact, 500 μM H2O2 induces FasL expression via NFkB (128). 
However, another report showed that the same concentration of H2O2 induces cell 
death independently of FasL (108). Interestingly, sustained H2O2 release from 
glucose oxidase in combination with ionomycin (but not each of the components 
alone) induces both FasL expression and FasL-dependent cell death (108). Human T 
cells seem to be much more sensitive to H2O2-induced apoptosis. However, it 
strongly depends on the T-cell subset that has been used in the study. In fact, 5 μM 
H2O2 induces apoptosis in human CD45RO+ Tmem, but not in CD45RA+ Tnai cells, via 
mitochondrial depolarization and caspase activation (129). Similarly, human CD4+ 
CD45RA+ Tnai cells are more resistant to cell death induced by 5-20 μM H2O2 than 
CD4+ CD45RA- Tmem cells (96). In contrast to conventional human T cells, Treg cells 
have lower intracellular ROS levels, as measured with DCFDA, and are resistant to 
H2O2-induced death (96). Moreover, 10 μM H2O2 does not affect Treg cell suppressive 
capacity (96). Interestingly, 100 μM H2O2 completely eliminates human CD4+ T cells, 
but has no effect on CD4+ T blasts (130). 
Various antioxidant compounds and overexpression of antioxidant enzymes are 
also used in order to understand the function of ROS in T-cell signaling and 
apoptosis. Jurkat T cells were most commonly used in these studies as well. 
Overexpression of PRX-2 leads to sustained MEK and ERK (but not JNK) activation 
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upon CD3 stimulation (111). Overexpression of MnSOD increases general tyrosine 
phosphorylation induced by CD3xCD28 stimulation, whereas overexpression of 
CuZnSOD decreases it (131). Moreover, MnSOD, but not CuZnSOD, enhances 
phosphorylation of JNK and p38 (131). NAC, Vitamin E, Butylated hydroxyanisole 
(BHA) and Nordihydroguaiaretic acid (NDGA) block PMA- and TNF-induced NFkB 
(but not AP-1) activation (124, 132). In another report, NAC, Vitamin E, and 
overexpression of MnSOD reduce NFkB and AP-1 (but not NFAT) activation upon 
PMAxIono stimulation (133, 134). Thus, various antioxidants exert diverse effects on 
signaling molecules, due to their specificity for different reactive oxygen species and 
distinct localization in the cell. 
Antioxidants can also block AICD in Jurkat T cells. Indeed, dithiothreitol, NAC, 
and overexpression of MnSOD prevent PMAxIono-induced FasL expression (108, 
118, 128). Accordingly, MnSOD overexpression reduces PMAxIono-triggered 
apoptosis (118). FasL upregulation upon CD3 stimulation is prevented by 
glutathione, NAC, and dithiothreitol (108, 128) (Fig. 1.10). In agreement with these 
observations, NAC diminishes CD3-induced cell death (108). Interestingly, only the 
thiol antioxidants glutathione, NAC, and 2-mercaptopropionylglycine (but not MnSOD 
overexpression, BHA, NDGA, Vitamin E analog Trolox, SOD mimetic MnTE-2-PyP, 
xanthine oxidase inhibitor allopurinol, or cyclooxygenase inhibitor indomethacin) 
reduce FasL-triggered apoptosis (115, 118, 135) (Fig. 1.10). Surprisingly, high GGT 
expression increases susceptibility to Fas-induced apoptosis (136). Interestingly, T 
cells targeted for apoptosis try to counteract the anti-apoptotic action of antioxidants. 
Indeed, FasL triggers glutathione efflux via specific anion-exchange transporter, and 
this is required for the activation of caspases and execution of the apoptotic program 
(137). Moreover, Fas ligation induces preferential calcium-dependent caspase-
mediated degradation of MnSOD in mitochondria (114) (Fig. 1.10).  
There is a limited amount of data on the effects of antioxidants on human T-cell 
blasts. NAC and overexpression of PRX-2 lead to sustained MEK and ERK 
phosphorylation but delayed AKT phosphorylation, upon CD3 stimulation (111). 
Additionally, NAC diminishes CD3-induced general tyrosine phosphorylation (90). 
Overexpression of CuZnSOD and MnSOD (but not catalase or TRX peroxidase) 
abrogates CD3-induced FasL expression (117) (Fig. 1.10). FasL upregulation and 
cell death upon CD3 stimulation are prevented by NAC (108, 118). Thus, FasL 
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expression (most likely via NFkB) in Jurkat and T-cell blasts is triggered by 
superoxide and can be prevented by overexpressing superoxide dismutase or by 
thiol antioxidants, whereas apoptotic cascades downstream of Fas can be blocked 
only by thiol antioxidants. Notably, Fas ligation triggers MnSOD degradation and 
glutathione efflux from the cell. 
In summary, it seems that several different sources of ROS are involved in 
AICD of T cells (Fig. 1.10). First, H2O2 produced by DUOX-1 in response to depletion 
of intracellular Ca2+ stores serves to amplify the initial T-cell receptor signaling, 
creating a positive feedback loop that involves DUOX-1, LCK, and PLCγ-1. Next, O2•- 
released from mitochondrial Complex I, downstream of DAG-dependent pathways, 
participates in the activation of NFkB and in the expression of FasL. Finally, Fas 
ligation activates NOX-2, which probably assists the execution of the apoptotic 
program via H2O2-mediated activation of p38, JNK, and AKT. Moreover, intracellular 
antioxidant glutathione interferes with FasL expression and caspase activation, thus 
counteracting AICD (Fig.1.10).  
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Figure 1.10 The role of ROS in T-cell apoptosis 
 
TCR triggering leads to the activation of LCK, ZAP-70, LAT, and PLCγ-1. 
PLCγ-1 converts PIP2 into IP3 and DAG. IP3 triggers its receptor (IP3R), thus 
leading to the efflux of calcium from endoplasmic reticulum. Released calcium 
activates DUOX-1, which is associated with IP3R. DUOX-1 produces H2O2 
that oxidizes SHP-2 and leads to the formation of a SHP-2-GAB-2-GRB-2-
PLCγ-1 complex, as well as to the activation of LCK. Thus, positive feedback 
loops involving DUOX-1, LCK, and PLCγ-1 are formed. DAG activates O2•- 
production by mitochondrial complex I (CI), through RAS-MEK and PKCθ. O2•- 
production leads to the activation of NFkB and expression of FasL. FasL 
triggers Fas that leads to the activation of caspases and cell death. Caspases 
selectively cleave MnSOD that converts part of O2•- into H2O2. Glutathione 
(GSH) interferes with the activation of NFkB and caspases, but Fas triggers 
GSH efflux from the cell. Additionally, Fas activates NOX-2. NOX-2 produces 
H2O2 that enters the cell and activates JNK, p38, and AKT but inhibits MEK. 
H2O2 is neutralized by PRX-2. Black solid arrows indicate production, black 
dashed arrows indicate export/import, green solid arrows indicate activation, 
red bar-headed lines indicate inhibition. Skull and bones indicate apoptosis. 
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Table 1. ROS and T-cell apoptosis 
 
Cell 
type 
Stimulatory 
agent 
ROS dye/ 
antioxidant 
ROS source Observed ROS effects Ref. 
Jurkat  
T cells 
 
PMA, PHA, 
ConA, FasL 
Luminol  ROS production (105, 106) 
PMA, PHA, 
PMAxIono, 
CD3 
DCFDA  ROS production (107-109) 
PMAxIono, 
CD3 
DCFDA Mitochondria ROS production (108, 110) 
CD3 DCFDA DUOX-1 Calcium flux; activation of 
LCK, ZAP-70, ERK, AP-1, 
NFAT 
(111, 112) 
CD3, FasL DHE  ROS production (111, 112, 
114, 115) 
CD3xCD28, 
FasL 
DHR Mitochondria ROS production (113, 115) 
FasL HPF  ROS production (115) 
CD3 PRX-2  Inhibition of MEK, ERK (111) 
CD3xCD28 MnSOD Mitochondria Inhibition of tyrosine 
phosphorylation, JNK, p38 
(131) 
CD3xCD28 CuZnSOD Cytosol Tyrosine phosphorylation (131) 
PMA, TNF NAC, Vitamin 
E, BHA, 
NDGA 
 Activation of NFkB (124, 132) 
PMAxIono DTT, NAC, 
Vitamin E, 
MnSOD 
 Activation of NFkB, AP-1; 
expression of FasL; 
apoptosis 
(108, 118, 
128, 133, 
134) 
CD3 GSH, NAC, 
DTT 
 Expression of FasL (108, 128) 
CD3, FasL GSH, NAC, 2-
MPG 
 Apoptosis (108, 115, 
118, 135) 
Human  
T-cell 
blasts 
CD3 
 
DCFDA, 
NAC, PRX-2 
 ROS production; activation 
of AKT; inhibition of MEK, 
ERK 
(111) 
DHE, 
CuZnSOD, 
MnSOD 
 ROS production; 
expression of FasL 
(117) 
DCFDA, DHE Mitochondria ROS production (108, 110, 
118) 
NAC  Tyrosine phosphorylation; 
expression of FasL; 
apoptosis 
(90, 108, 
118) 
Human  
CD4+  
T-cell 
blasts 
CD3 DCFDA DUOX-1 ROS production; activation 
of ZAP-70, PLCγ-1, ERK; 
association of PLCγ-1, 
SHP-2, GAB-2 and GRB-2 
(112) 
Murine  
T-cell 
blasts 
 
CD3, FasL DCFDA NOX-2 ROS production; activation 
of MEK, ERK; inhibition of 
AKT 
(116) 
CD3 DCFDA Other than 
NOX-2 
ROS production (116) 
FasL DHE Other than 
NOX-2 
ROS production (116) 
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1.4.3 ROS and T-cell activation 
 
The role of ROS in T-cell activation, correlating with productive T-cell 
responses, such as proliferation and differentiation, can be studied only in primary T 
cells. T-cell blasts, as well as Jurkat T cells or other T-cell lines, are, on the contrary, 
already activated cells, and will undergo AICD upon TCR stimulation (29). There is 
evidence that primary human and murine T cells produce ROS upon stimulation with 
different agents. However, it cannot be excluded that the detected ROS originate 
from contaminating phagocytic cells, which are almost inevitably present in any 
preparation of primary T cells. Phagocytes can be activated by various agents used 
to stimulate T cells, for example by PMA or by anti-TCR antibodies via Fc receptors 
(138). Ideally, the purity of T-cell preparation should be very high (>99%), and an 
isotype-matched control antibody should be used to discriminate between the T cell-
derived ROS and the ROS of phagocytic origin. Unfortunately, these conditions have 
been rarely met, if ever. Moreover, activated T cells can induce respiratory burst in 
phagocytes by direct contacts (83). Thus, the detection of specific T cell-derived ROS 
is a challenging task. In the following paragraph, I will describe the studies that 
attempted to measure ROS production in human or murine primary T cells (see also 
Table 2).  
PMA or PHA stimulation of human T cells induces DCFDA oxidation (107, 139). 
CD3 and especially CD28 stimulation induces DCFDA oxidation and decreases the 
intracellular glutathione levels in human T cells (140). This ROS production is 
mediated by 5-lipoxygenase (140) (Fig. 1.11). Human CD45RA+ Tnai cells induce 
more DCFDA oxidation than CD45RO+ Tmem cells, upon CD3, CD28, and CD3xCD28 
stimulation (141). Notably, CD45RO+ Tmem cells do not induce DCFDA oxidation upon 
CD28 stimulation alone (141). CD3, CD28, PMA, and ionomycin induce DCFDA 
oxidation in murine CD8+ T cells (139). CD3 stimulation of murine CD4+ T cells 
induces p47phox-dependent DCFDA oxidation (142) (Fig. 1.11). Surprisingly, 
CD3xCD28-induced oxidation of the chloromethyl DCFDA derivative (CM-DCFDA) is 
enhanced in T cells from gp91phox-/- mice (119). CD3 or CD3xCD28 (but not CD28 
alone) stimulation of murine CD4+ T cells induces oxidation of mitochondrial 
reduction-oxidation sensitive Green Fluorescent Protein (mito-roGFP) that is 
dependent on mitochondrial calcium uptake (143). Moreover, CD3xCD28 or 
PMAxIono stimulation of murine CD4+ T cells induces oxidation of the mitochondria-
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targeted superoxide-sensitive dye MitoSOX that is dependent on mitochondrial 
Rieske Iron-sulfur Protein (RISP) (143) (Fig. 1.11). Chemokine (C-X-C Motif) Ligand 
12 (CXCL-12) stimulation of murine CD4+ T cells induces CM-DCFDA oxidation that 
is abrogated by catalase and is markedly reduced in aquaporin 3-deficient cells, 
indicating the involvement of extracellular H2O2 (121). Collectively, the data reported 
above suggest that triggering of the TCR, CD28, or CXCR-4 in primary T cells leads 
to ROS production by 5-lipoxygenase, NOX-2, and mitochondria. 
T cells from mice lacking components of NOX-2 could serve as a good model to 
study the function of NOX-2-derived ROS in T-cell activation. Nevertheless, the 
interpretation of the results obtained using this model should be taken with caution, 
as phagocytes from these mice also lack NOX-2, and this may indirectly affect T-cell 
functions. T cells from p47phox-/- mice have diminished expression of T-bet, Signal 
Transducer and Activator of Transcription 1 (STAT-1), and STAT-4, reduced DNA 
synthesis, and decreased production of IL-2, IL-4, IFNγ, TNFα, and GM-CSF, upon 
CD3xCD28 stimulation (142). Additionally, those T cells have increased 
phosphorylation of STAT-3 and production of IL-10, IL-17, and TGFβ (142). CD4+ T 
cells from gp91phox-/- mice produce less IL-4 and IL-5 but more IL-17 and IFNγ than 
WT counterparts, upon CD3xCD28 stimulation (144) (Fig. 1.11). Moreover, they have 
reduced GATA-3 expression and STAT-5 and STAT-6 phosphorylation, but 
increased T-bet expression (144). Interestingly, they have no defect in CD25 
expression or IL-2 production (144). Thus, NOX-2 is required for proper 
differentiation and migration but not for the activation of primary murine T cells. 
Another approach to elucidate the role of ROS in the activation of primary T 
cells is the exogenous addition of H2O2 and the evaluation of its effects on T-cell 
functions. 10 μM H2O2 reduce thapsigargin-triggered calcium flux in CD4+ human T 
cells (130). However, 10-100 μM H2O2 induce CRAC channel-independent calcium 
flux (130). 10-1000 μM H2O2 induce NFkB activation in human CD45RA+ Tnai cells 
stronger than in CD45RO+ Tmem cells (145). Nevertheless, another study showed that 
25-100 μM H2O2 suppress CD3-induced NFkB activation in human T cells (146). High 
concentrations (≥30 μM) of H2O2 inhibit ConA-stimulated DNA synthesis in murine T 
cells, whereas low concentrations (3-10 μM) augment it (147). Furthermore, 100 μM 
H2O2 reduce IL-2 production by CD3xCD28-stimulated CD4+ human T cells (130). 
100 μM H2O2 induce ITK and Cell Division Cycle protein 42 (CDC-42) activation in 
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murine CD4+ T cells (148). Moreover, CXCL-12-induced activation of CDC-42 and 
ITK, polymerization of actin, and migration of murine CD4+ T cells are reduced in 
aquaporin 3-deficient cells but are reconstituted upon the addition of 100 μM H2O2 
(148). In summary, the effects of exogenous H2O2 on primary T cells strongly depend 
on H2O2 concentration and are rather contradictory, which might be due to non-
physiological nature of such stimuli and to the experimental conditions used in these 
studies. 
Another alternative approach that has been used to understand the functional 
importance of ROS in primary T-cell activation is based on the addition of 
antioxidants. NDGA inhibits IL-2 production by PHA-stimulated human T cells (149). 
On the other side, BHA blocks DNA synthesis and CD25 expression (but not IL-2 
production) in murine T cells stimulated with PMAxIono (150). IL-2R expression by 
murine T cells upon stimulation with ConA or PMAxA23187 (calcium ionophore) is 
suppressed by NDGA and BHA (151). Vitamin E suppresses IL-4 production in 
PMAxIono- or CD3xCD28-stimulated human T cells (133). Mitochondria-targeted 
vitamin E abrogates CD3xCD28- or PMAxIono-induced IL-2 production in murine 
CD4+ T cells (143). The NAC and NOX-2 inhibitor apocynin reduces STAT-5 
phosphorylation in murine CD4+ T cells upon CD3xCD28-stimulation to the levels 
observed in gp91phox-/- mice (144). Catalase suppresses CXCL-12-induced activation 
of CDC-42 and ITK, polymerization of actin, and migration of murine CD4+ T cells 
(148). It seems that antioxidants that inhibit lipid peroxidation and/or lipoxygenase 
activity (such as NDGA, BHA, Vitamin E, and Mitovitamin E) can interfere with CD25 
expression, cytokine production, and DNA synthesis in primary T cells (Fig. 1.11). 
Therefore, it is likely that the reduction in the synthesis of leukotrienes 
(proinflammatory molecules downstream of lipoxygenase), rather than the reduction 
in ROS levels, could be the reason for the impairment of T-cell activation by those 
antioxidants. 
Signaling ROS exert their function by interacting with particular cysteine 
residues, thus modulating protein functions. Stimulation of murine CD8+ T cells with 
CD3xCD28 or PMAxIono induces protein sulfenylation (as assessed by the 
dimedone method (152)) that could be reduced by NAC (139). It has been shown 
that SHP-1 and SHP-2 are transiently sulfenylated (139). Moreover, it has been 
shown that dimedone binding to sulfenic acids interferes with CD3xCD28- or 
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PMAxIono-induced proliferation of murine CD4+ and CD8+ T cells, but only if 
dimedone is continuously present in the medium (139). Dimedone also interferes with 
PMAxIono-induced calcium flux, ERK phosphorylation, protein and DNA synthesis, 
and cell growth, but not p38 or JNK phosphorylation or cell viability, in murine CD8+ T 
cells (139). Thus, sulfenylation is likely involved in a wide range of processes within T 
cells. 
Collectively, it seems that ROS produced by NOX-2 are involved in 
differentiation and migration of T cells, but not in the initial phases of T-cell activation. 
The functional importance of ROS from other sources, such as mitochondria, is not 
yet clear. Moreover, a possibility remains that even NOX-2-derived ROS are 
produced by surrounding phagocytic cells and not by T cells themselves. 
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Figure 1.11 The role of ROS in T-cell activation 
 
The ligation of CD28 leads to the activation of the lipoxygenase pathway 
(LOX). This enhances the expression of CD25, IL-2, and IL-4. The triggering 
of TCR leads to O2•- production by mitochondrial complex III (CIII). Whether 
this superoxide has any function is not clear. Additionally, the ligation of TCR 
or CXCR-4 leads to the activation of NOX-2. NOX-2 produces H2O2 that 
enters the cell predominantly via aquaporin channels (AQP). Inside the cell, 
H2O2 activates CDC-42, ITK, GATA-3, and STAT-6, but inhibits STAT-3. 
Activated CDC-42 initiates actin polymerization and cell migration. ITK is 
involved in multiple processes. GATA-3 and STAT-6 direct T-cell 
differentiation towards Th2 phenotype and production of IL-4 and IL-5. STAT-3 
leads to Th17 differentiation and IL-17 production. Black dashed arrow 
indicates import, green solid arrows indicate activation, red bar-headed line 
indicates inhibition. 
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Table 2. ROS and T-cell activation 
 
Cell 
type 
Stimulatory 
agent 
ROS dye/ 
antioxidant 
ROS source Observed ROS effects Ref. 
Human  
T cells 
 
PMA, PHA, 
CD3, CD28, 
CD3xCD28 
DCFDA  ROS production (107, 139, 
141) 
CD28, CD3 DCFDA Lipoxygenase ROS production (140) 
PHA NDGA Lipoxygenase? IL-2 production (149) 
PMAxIono, 
CD3xCD28 
Vitamin E Lipoxygenase? IL-4 production (133) 
Murine  
T cells 
ConA, 
PMAxIono, 
PMAxA23187 
NDGA, BHA Lipoxygenase? DNA synthesis; IL-2R 
(CD25) expression 
(150, 151) 
CD3xCD28 CM-DCFDA Other than 
NOX-2 
ROS production (119) 
Murine 
CD4+  
T cells 
 
CD3, 
CD3xCD28 
DCFDA NOX-2 ROS production; 
activation of T-bet, 
STAT-1, STAT-4; DNA 
synthesis; production of 
IL-2, IL-4, IFNγ, TNFα, 
GM-CSF; inhibition of 
STAT-3, IL-10, Il-17, 
TGFβ 
(142) 
CD3xCD28 Apocynin, 
NAC 
NOX-2 Activation of GATA-3, 
STAT-5, STAT-6; 
production of IL-4, IL-5; 
inhibition of T-bet, IL-17, 
IFNγ 
(144) 
CD3, 
CD3xCD28, 
PMAxIono 
Mito-roGFP, 
MitoSOX 
Mitochondria ROS production (143) 
CD3xCD28, 
PMAxIono 
Mitovitamin E Mitochondria 
or 
lipoxygenase? 
IL-2 production (143) 
CXCL-12 CM-DCFDA, 
catalase 
Extracellular ROS production; 
activation of CDC-42, 
ITK; polymerization of 
actin; migration 
(148) 
Murine 
CD8+ 
T cells 
CD3, CD28, 
PMA, 
ionomycin 
DCFDA  ROS production (139) 
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1.5 Mitochondria and T-cell activation 
 
Despite the widespread idea that, upon activation, T cells switch from 
mitochondrial respiration and fatty acid oxidation to aerobic glycolysis (153, 154), it 
has been recently shown that CD4+ T cells can use both metabolic pathways for 
proliferation (143, 155), although it appears that glycolysis is required mainly for Teff 
cell function (155). While Th cells depend on glycolysis, Treg cells require 
mitochondrial lipid oxidation (156). Interestingly, CD8+ Tmem cells have more 
mitochondria than Teff cells and depend on fatty acid oxidation (157, 158). Thus, 
mitochondrial metabolism is essential for Tmem and Treg cell function. 
Several mitochondrial processes participate in the activation of T cells. First of 
all, mitochondrial ATP production is required for CD25 and CD44 expression and 
initial proliferation of murine CD4+ T cells (155) (Fig.1.12). In addition, calcium 
buffering by mitochondria is necessary for sustained CRAC-mediated calcium flux 
and NFAT activation in Jurkat T cells (113, 159, 160). To mediate efficient calcium 
uptake, mitochondria translocate to the immunological synapse (161-164). Thus, 
mitochondrial ATP production and calcium buffering are required for T-cell activation. 
Both ATP synthesis and calcium uptake are powered by mitochondrial 
membrane potential (MMP) (165, 166) (Fig.1.12). Murine CD8+ T cells, activated in 
vivo by lymphocytic choriomeningitis virus (LCMV), have elevated MMP, which then 
decreases during the contraction phase of the immune response (167). Mitochondrial 
biogenesis and MMP increase after stimulation of murine T cells (168). Interestingly, 
in human CD4+ T cells, MMP drops immediately after stimulation, but is required for 
IL-2 expression (113). Thus, MMP seems to be proportional to the activation state of 
T cells, at least in mice. 
MMP is maintained by the activity of the ETC, which consists of complexes I-IV. 
Mitochondrial complex I is required for CD95L expression and AICD in Jurkat T cells 
and human T-cell blasts (110) and also for ERK phosphorylation, CD69 expression, 
proliferation, and TNFα production in murine CD8+ T cells (169), as well as for IL-2 
and IL-4 production in human T cells (113, 134). The mitochondrial complex III 
subunit RISP is required for NFAT (but, surprisingly, not for ERK or for NFkB) 
activation, CD25 and CD69 expression, and IL-2 production in murine CD4+ T cells, 
as well as in vivo antigen-specific expansion of CD4+ and CD8+ T cells (143). Specific 
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involvement of complex III in the activation of NFAT suggests that MMP-dependent 
calcium buffering is the primary function of mitochondria in T-cell activation. Thus, 
ETC complexes I and III have been shown to be required for T-cell activation, 
proliferation, and cytokine production, as well as for AICD. 
In conclusion, MMP seems to correlate with the state of T-cell activation. 
Indeed, MMP is required for mitochondrial ATP synthesis and calcium buffering – 
processes that were shown to be essential for the activation of T cells. Moreover, 
disruption of MMP by inhibition or by knockout of ETC complexes I or III leads to 
severe defects in T-cell activation, proliferation, cytokine production, and AICD. 
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Figure 1.12 The role of mitochondria in T-cell activation 
 
The triggering of the TCR leads to an increase in the activity of mitochondrial 
ETC, which pumps protons (H+) across the inner mitochondrial membrane, 
creating MMP. ETC is fueled mainly by the catabolism of fatty acids (FA). TCR 
ligation also activates PLCγ-1, which generates IP3 from PIP2. IP3 triggers its 
receptor on endoplasmic reticulum, leading to the release of Ca2+. This event 
activates CRAC, resulting in the influx of extracellular Ca2+. Mitochondria 
scavenge Ca2+ with mitochondrial calcium uniporter (MCU), which is powered 
by MMP. Ca2+ is then slowly released, allowing the sustained activation of 
NFAT via calcineurin. NFAT activation leads to the expression of IL-2. MMP 
also fuels mitochondrial ATP synthase. Mitochondria-derived ATP is required 
for the expression of CD25 and CD44. Black solid arrows indicate production, 
black dashed arrows indicate import/export, green solid arrows indicate 
activation. 
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1.6 The aim of this work 
 
Investigations on the role of ROS in T cells have an almost 30-year-long history 
(98, 100, 107, 147, 150). It has been shown that phagocytic cells can induce 
oxidative stress in T cells, leading to unresponsiveness, but also that dendritic cells 
can secrete antioxidant precursors to help T-cell proliferation (see section 1.4.1). It 
has been additionally shown that the re-stimulation of previously activated T cells, 
such as T-cell blasts and Jurkat T cells, triggers ROS production that leads to death 
receptor upregulation and activation-induced cell death (see section 1.4.2). However, 
studies investigating the function of ROS in the activation of primary T cells are 
limited (see section 1.4.3). There is especially a profound lack of knowledge about 
the role of ROS in the activation of human primary T cells, the most relevant cell 
target for clinical applications. 
Another important issue to take into account is the agent used for stimulation. 
Many studies employed relatively non-specific and/or artificial substances, such as 
Concanavalin A, PHA, PMA, or ionomycin, which complicate the interpretation of the 
results. Even in cases where stimulation with CD3 and CD28 antibodies was used, 
they were often added in solution, not immobilized on plates or microbeads. It has 
been recently shown that soluble stimulation leads to T-cell unresponsiveness, 
whereas stimulation with immobilized antibodies results in T-cell activation (170, 
171). Thus, it is important to study the function of ROS under stimulation conditions 
correlating with productive T-cell responses, such as proliferation. Finally, it also has 
to be considered that phagocytic cells are almost inevitably present in T-cell 
preparations from human peripheral blood. These cells can be activated by anti-TCR 
antibodies through Fc receptors (138). Therefore, to differentiate between ROS 
produced by T cells and those released by phagocytes, isotype control antibodies 
have to be used in each experiment. This has almost never been done.  
When antioxidants are used to assess the role of ROS in T-cell activation, it is 
important to choose substances with minimal off-target effects. For example, most 
antioxidants that were shown to affect the activation of T cells are also inhibitors of 
the lipoxygenase pathway – a pathway crucial for the synthesis of proinflammatory 
leukotrienes (see section 1.4.3) – and hence may modulate T-cell function in an 
oxidation-independent manner. Therefore, natural and more specific antioxidants, 
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such as superoxide dismutase, catalase, and ascorbate, are a better choice to 
elucidate the importance of ROS in T cells. Mice with the specific knockouts of ROS-
producing enzymes, such as gp91phox-/- mice, are also excellent tools. However, it is 
not possible to perform a specific knockdown in human T cells without inducing 
cellular stress, which will inevitably lead to stress-mediated ROS generation. 
Based upon these concerns, the aim of this work was to elucidate the 
involvement of ROS in the activation, proliferation, and differentiation of T cells under 
conditions that mimic physiological settings as closely as currently possible. To avoid 
the problems described above, I have measured ROS production in primary human 
and mouse T lymphocytes upon stimulation with CD3 and CD28 monoclonal 
antibodies immobilized on microbeads and used isotype-coated beads as control. 
Next, I have investigated the effects of superoxide dismutase, catalase, and 
ascorbate on the activation, proliferation, and cytokine profile of primary human T 
cells. Finally, I have characterized primary T cells from gp91phox-/- mice to assess 
whether NOX-2-derived ROS play any role in the activation of T cells. I have found 
that primary T cells produce extracellular superoxide via NOX-2 upon TCR 
stimulation, but this superoxide is not required for T-cell activation, proliferation, and 
differentiation. 
Mitochondria have been implicated in T-cell activation, proliferation, cytokine 
production, and AICD (see section 1.5). Fatty acid catabolism, ATP synthesis, 
calcium uptake, and ROS production have been proposed to participate in these 
processes. However, it is not clear which mitochondrial function plays the major role. 
Again, very little is known about the involvement of mitochondria in the activation of 
human primary T cells. Therefore, in the second part of this work, I have studied the 
effects of various mitochondrial inhibitors on signaling, expression of activation 
markers and ROS production in primary human T cells. I have found that 
mitochondrial membrane potential, but not mitochondria-derived ROS or ATP, is 
crucial for the activation of primary human T cells. 
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2 Results 
2.1 Measurements of TCR-triggered ROS  
 
There are few studies investigating ROS production in primary T cells, 
especially in human primary T cells. Moreover, the majority of those studies have 
employed non-physiological types of stimulation, such as PMA and ionomycin or 
CD3 and CD28 antibodies added in solution, which lead to T-cell hyperactivation or 
unresponsiveness (170), respectively. In addition, many studies have not 
discriminated between the T cell-derived ROS and the ROS generated by phagocytic 
cells. In fact, phagocytes are usually present in preparations of primary T cells and 
can be easily activated by the same stimulatory agents. 
Based upon these concerns, the goal of the first part of my work was to 
measure ROS production specifically in primary T cells using more physiological 
stimulation. To this aim, I have measured ROS production in primary human and 
mouse T lymphocytes upon stimulation with CD3 and CD28 monoclonal antibodies 
immobilized on microbeads, and I have used isotype-coated beads as control. 
 
2.1.1 Phagocytes interfere with ROS measurements in primary T-cell 
cultures 
 
Firstly, I have decided to measure ROS production in primary human T cells 
with the most commonly used ROS-sensitive fluorescent indicator – DCFDA. 
Peripheral blood T cells were isolated from healthy volunteers by negative magnetic 
sorting to avoid the preactivation of the cells. Subsequently, the cells were loaded 
with DCFDA and stimulated with anti-CD3 and anti-CD28 monoclonal antibodies 
(mAbs) immobilized on microbeads (CD3xCD28) to mimic a physiological stimulation 
(170). At 15 and 30 minutes after stimulation, the cells were diluted in ice-cold PBS, 
to terminate the stimulation, and were analyzed by flow cytometry, gating on 
lymphocytes according to their physical parameters (on the FSC-SSC dot plot). I 
have detected a moderate increase in the fluorescence of the dye upon CD3xCD28 
stimulation (Fig. 2.1 A). However, the oxidation of the dye induced by microbeads 
coated with the isotype control antibodies was identical to that observed upon 
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CD3xCD28 stimulation. Therefore, I concluded that the ROS production was 
triggered in a TCR-independent fashion.  
Microbeads coated with immunoglobulins mimic opsonized pathogens and thus 
may activate phagocytic cells via Fc receptors (138, 172). I have indeed identified a 
small percentage of CD14+ and CD16+ (the markers for monocytes and neutrophils) 
cells in my T-cell preparations (Fig. 2.1 B). If ROS detectable with DCFDA are 
produced by phagocytic cells present in T-cell preparations, then I should have 
observed more dye oxidation in cell cultures enriched in phagocytes, such as 
peripheral blood mononuclear cells (PBMCs). Indeed, as shown in Fig. 2.1 C, 
lymphocytes gated within isolated PBMCs exhibit very strong DCFDA oxidation upon 
stimulation with microbeads coated with either anti-CD3 and anti-CD28 mAbs or the 
isotype controls. Conversely, no detectable ROS production is observed upon 
stimulation of in vitro expanded T-cell blasts or Jurkat T cells, which do not contain 
contaminating phagocytic cells (Fig. 2.1 C). Interestingly, when PBMCs are 
stimulated with beads not coupled to antibodies, the increase in DCFDA oxidation 
within lymphocytes is much weaker (Fig. 2.1 D). This implies that ROS production is 
indeed triggered mostly by Fc receptor-mediated phagocyte activation. 
From these experiments, I have concluded that the employed method is not 
suitable to detect ROS upon TCR triggering in primary cultures of human T cells. 
Even if T cells produce very low amounts of ROS, these cannot be detected, as they 
are masked by ROS from phagocytic cells. Therefore, a more sensitive method to 
detect ROS is required to address the question of whether T cells produce ROS upon 
TCR triggering. Moreover, it is known that DCFDA has low sensitivity for superoxide 
(O2•-) (173). Therefore, even if O2•- is the main reactive species produced by T cells in 
response to TCR stimulation, it is not detectable by DCFDA. 
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Figure 2.1 Phagocytes interfere with ROS measurements in primary T-
cell cultures 
In (A), (C) and (D), the cells were loaded with DCFDA and stimulated with the 
indicated antibodies. DCFDA fluorescence was measured by FACS upon setting a 
gate on lymphocytes according to their physical parameters (on the FSC-SSC dot 
plot). The values indicate the increase in the mean fluorescence intensity in the 
stimulated vs. unstimulated samples. P values were determined by two-tailed 
Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001). 
 
(A) Primary human T cells were stimulated with CD3xCD28- or isotype-coated 
microbeads for 15 min (n=3) or 30 min (n=15).  
(B) A preparation of primary human T cells was stained with the indicated 
fluorescently labeled antibodies and analyzed by FACS (n=3). 
(C) Primary human T cells (n=15), PBMCs (n=4), Jurkat T cells (n=7), or human T-
cell blasts (n=5) were stimulated with CD3xCD28- or isotype-coated 
microbeads for 30 min. 
(D) PBMCs were stimulated with uncoated or isotype-coated microbeads for 30 
min (n=3). 
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2.1.2 TCR stimulation induces the extracellular release of superoxide in 
primary human T cells 
 
In order to shed more light onto ROS production in T cells, I have decided to 
use the luminol-based assay Diogenes, which predominantly detects O2•-. In line with 
the DCFDA measurements, I have detected some oxidation of luminol upon the 
addition of isotype-coated microbeads to T-cell preparations, likely indicating O2•- 
production by contaminating phagocytic cells (Fig. 2.2 A). However, CD3xCD28-
coated microbeads induce the significantly stronger oxidation of luminol (Fig. 2.2 A). 
When the data are presented as the ratio of the oxidation induced by CD3xCD28 vs. 
the oxidation induced by isotype controls, the specific increase in O2•- production by 
CD3xCD28-stimulated T cells becomes even more clear (Fig. 2.2 B). The peak 
(about 35% increase over the isotype controls) in the TCR-specific O2•- production 
occurs 10 min after TCR-triggering, whereas ROS levels decrease gradually 
afterwards.  
The superoxide-neutralizing enzyme superoxide dismutase (SOD), but not the 
hydrogen peroxide-neutralizing enzyme catalase, prevents the luminol oxidation, 
indicating that the detected reactive species is indeed O2•- (Fig. 2.2 C). These results 
also suggest that O2•- is released into the extracellular space, as SOD is membrane-
impermeable. Interestingly, there is no detectable extracellular O2•- production upon 
CD3xCD28 stimulation of human T-cell blasts and Jurkat T cells (data not shown). 
On the contrary, PBMCs, which contain phagocytic cells, induce very strong O2•- 
production (Fig. 2.2 D). In summary, my data show that primary human T cells 
produce O2•- upon TCR stimulation and release it into the extracellular space. 
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Figure 2.2 TCR stimulation induces the extracellular release of 
superoxide in primary human T cells 
  O2•- levels were measured using the Diogenes assay. P values were 
determined by two-tailed Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001). 
(A) Primary human T cells were stimulated with CD3xCD28- or isotype-coated 
microbeads (n=16). The values indicate the increase in luminescence in the 
bead-stimulated samples relative to the unstimulated samples. 
(B) Primary human T cells were stimulated with CD3xCD28- or isotype-coated 
microbeads (n=16). The values indicate the increase in luminescence in the 
CD3xCD28-stimulated samples relative to the isotype-stimulated samples. 
(C) Primary human T cells were stimulated for 10 min with CD3xCD28-coated 
microbeads alone or in the presence of SOD or catalase (n=4). The values 
indicate the luminescence signal normalized to the stimulated control. 
(D) Primary human T cells or PBMCs were stimulated with CD3xCD28-coated 
microbeads (n=2). The values indicate the increase in luminescence in the 
CD3xCD28-stimulated samples relative to the unstimulated samples. 
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2.2 The function of extracellular superoxide in T-cell 
activation 
 
Most of the antioxidants used in many studies are also inhibitors of leukotriene 
production and hence may modulate T-cell activation in a ROS-independent manner. 
Based upon this concern, the goal of this part of the work was to elucidate the 
function of ROS in primary T cells using natural antioxidants and specific knockouts. 
To this aim, I have investigated the effects of SOD, catalase, and ascorbate on the 
activation, proliferation, and cytokine profile of primary human T cells upon 
stimulation with CD3xCD28-coated microbeads. I have also analyzed primary T cells 
from gp91phox-/- mice to assess whether NOX-2-derived ROS play any role in the 
activation of T cells.  
 
2.2.1 Natural antioxidants efficiently neutralize extracellular ROS 
 
In the previous part, I have shown that the main detectable reactive species 
produced by T cells upon TCR triggering is O2•-. Moreover, I have shown that 
extracellular O2•- can be neutralized by the addition of SOD (Fig. 2.2 C). This allowed 
me to investigate its functional role in T cells, using SOD as a tool. Two additional 
natural antioxidants were also tested – ascorbate and glutathione. Ascorbate is as 
efficient as SOD, whereas glutathione is two-fold less efficient (scavenging only half 
of inducible O2•-) (Fig. 2.3 A). Therefore, glutathione was not further used in my 
studies. As O2•- can naturally dismutate to hydrogen peroxide (H2O2), which 
potentially can also affect T cells, I have included samples treated with catalase in 
the functional assays. The efficiency of catalase in removing H2O2 is confirmed using 
DCFDA (Fig. 2.3 B), as the Diogenes detects almost exclusively O2•-. SOD, 
ascorbate, and catalase are essential parts of the cell-intrinsic antioxidant defense 
system and therefore can be used for functional assays without inducing off-target 
effects. 
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Figure 2.3 Natural antioxidants efficiently neutralize extracellular ROS 
(A) Primary human T cells were stimulated for 10 min with CD3xCD28-coated 
microbeads alone or in the presence of ascorbate or glutathione (n=4). O2•- 
was measured using the Diogenes assay. The values indicate the 
luminescence intensities normalized to the stimulated control. P values were 
determined by two-tailed Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001). 
(B) Primary human T cells were loaded with DCFDA and stimulated for 30 min 
with 100 μM H2O2 alone or in the presence of catalase (n=3). DCFDA 
fluorescence was measured by FACS. The values indicate the mean 
fluorescence intensities normalized to the stimulated control. P values were 
determined by two-tailed Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001). 
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2.2.2 Extracellular superoxide is not required for T-cell activation, 
proliferation, and cytokine production 
 
In the previous section, I have shown that SOD, ascorbate, and catalase can be 
used to remove extracellular O2•- and hence to assess its importance for T-cell 
activation. To investigate the role of extracellular O2•- in T cells, I have first stimulated 
primary human T cells with CD3xCD28-coated microbeads for 16 hours in the 
presence of the antioxidants and assessed T-cell activation by FACS, using 
fluorescently labeled antibodies against surface activation markers (Fig. 2.4 A). To 
my surprise, the addition of SOD, ascorbate, or catalase had no major effect either 
on the expression of CD25 and CD69 (Fig. 2.4 B) or on the percentage of 
CD25+CD69+ cells (Fig. 2.4 C). 
Next, I have investigated proliferation of CD3xCD28-stimulated human T cells in 
the presence of SOD, ascorbate, and catalase using a CFSE dilution assay (Fig. 2.5 
A). Consistent with the results presented above, I have observed normal percentages 
of the proliferating cells 3 days after the stimulation in the presence of the 
antioxidants (Fig. 2.5 B). 
I have then decided to investigate if extracellular O2•- is involved in the 
regulation of CD4+ T-cell differentiation. To this aim, I have stimulated human CD4+ 
Tnai cells with CD3xCD28-coated microbeads in the presence of the antioxidants and 
measured the concentrations of various cytokines in the supernatants after 48 hours, 
using the Bio-Plex system. No significant differences were observed between the 
samples (Fig. 2.6). 
Overall, these data demonstrate that in human T cells extracellular O2•- is 
dispensable for activation, proliferation, and cytokine production. 
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Figure 2.4 Extracellular superoxide is not required for the activation of 
human T cells 
(A) Primary human T cells were stimulated with CD3xCD28-coated microbeads 
alone or in the presence of either SOD, catalase, or ascorbate (n=3). After 16 
hours, the cells were stained with CD25-FITC and CD69-PE mAbs and 
analyzed by FACS. 
(B) Quantification of (A). The values indicate the mean fluorescence intensities of 
CD25 and CD69 staining normalized to the stimulated control. P values were 
determined by two-tailed Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001). 
(C) Quantification of (A). The values indicate the percentages of CD25+CD69+ 
cells normalized to the stimulated control. P values were determined by two-
tailed Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001). 
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Figure 2.5 Extracellular superoxide is not required for the proliferation of 
human T cells  
(A) Primary human T cells were loaded with CFSE and stimulated with 
CD3xCD28-coated microbeads alone or in the presence of either SOD, 
catalase, or ascorbate (n=3). After 72 hours, the CFSE dilution was analyzed 
by FACS. 
(B) Quantification of (A). The values indicate the percentages of the proliferating 
cells normalized to the stimulated control. P values were determined by two-
tailed Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001). 
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Figure 2.6 Extracellular superoxide is not required for cytokine production 
by human CD4+ T cells 
Human CD4+ Tnai cells were stimulated with CD3xCD28-coated microbeads 
alone or in the presence of either SOD, catalase, or ascorbate (n=3). After 48 hours, 
supernatants were collected. The cytokine concentrations were measured using the 
Bio-Plex Pro assay. The values indicate the cytokine concentrations normalized to 
the stimulated controls. P values were determined by two-tailed Student’s t test 
(*P < 0.05, **P < 0.01, ***P < 0.001). 
 
  
 
64 
2.3 The role of NOX-2 in T cells 
 
2.3.1 TCR-triggered superoxide production is mediated by NOX-2 in 
primary T cells 
 
I have shown that primary T cells produce extracellular O2•- upon TCR 
stimulation. One of the most-well described sources of inducible O2•- production is the 
phagocytic NADPH oxidase 2 (NOX-2). Remarkably, NOX-2 has been shown to be 
expressed in human and murine T-cell blasts (116, 119). I have decided to use T 
cells from NOX-2-deficient mice (gp91phox-/-) to investigate whether NOX-2 is the 
source of the TCR-triggered O2•- production. Splenic T cells from wild type (WT) mice 
produce O2•- upon the CD3xCD28 microbead stimulation, similarly to the human T 
cells albeit with faster kinetics (Fig. 2.7 A). On the contrary, T cells from gp91phox-/- 
mice show no inducible O2•- production upon TCR stimulation (Fig. 2.7 A). Moreover, 
isotype-coated microbeads induce O2•- production in WT but not in gp91phox-/- cells, 
thus confirming my hypothesis that phagocytic cells produce ROS upon antibody 
stimulation (Fig. 2.7 B). Therefore, these data demonstrate that NOX-2 is indeed 
activated upon TCR triggering in primary T cells and that NOX-2 is responsible for 
the rapid generation of O2•-. 
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Figure 2.7 TCR-triggered superoxide production is mediated by NOX-2 in 
primary T cells 
(A and B) Splenic T cells from either WT (n=6) or gp91phox-/- (n=12) mice were 
stimulated with CD3xCD28- or isotype-coated microbeads. O2•- was measured using 
the Diogenes assay at 5 min intervals. P values were determined by two-tailed 
Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001). 
(A) The values indicate the increase in luminescence intensity in the CD3xCD28- 
relative to the isotype-stimulated samples. 
(B) The values indicate the increase in luminescence intensity in the bead-
stimulated samples relative to the unstimulated samples. 
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2.3.2 NOX-2 deficiency does not affect T-cell activation and proliferation 
 
To assess the importance of NOX-2 in T-cell functions, I have compared the 
activation and proliferation of gp91phox-/- and WT T cells upon CD3xCD28 microbead 
stimulation. In line with my observations of human T cells treated with antioxidants 
(Fig. 2.4, Fig. 2.5), the upregulation of the activation markers CD69 and CD25 (Fig. 
2.8 A, B), the percentage of CD69+CD25+ cells (Fig. 2.8 A, C), and proliferation (Fig. 
2.9) are not affected in the T cells from gp91phox-/- mice. Altogether, my data suggest 
that TCR-triggered extracellular O2•- production via NOX-2 is dispensable for the 
activation of primary T cells. 
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Figure 2.8 NOX-2 is not required T-cell activation 
(A) Splenic T cells from WT (n=2) or gp91phox-/- (n=4) mice were stimulated with 
CD3xCD28-coated microbeads. After 16 hours, cells were stained with CD25-
FITC and CD69-PE mAbs and analyzed by FACS.  
(B) Quantification of (A). The values indicate the mean fluorescence intensities. P 
values were determined by two-tailed Student’s t test (*P < 0.05, **P < 0.01, 
***P < 0.001). 
(C) Quantification of (A). The values indicate the percentages of CD69+CD25+ 
cells. P values were determined by two-tailed Student’s t test (*P < 0.05, 
**P < 0.01, ***P < 0.001). 
 
 
Figure 2.9 NOX-2 is not required for T-cell proliferation 
(A) Splenic T cells from WT (n=4) or gp91phox-/- (n=8) mice were loaded with CFSE 
and stimulated with CD3xCD28-coated microbeads. After 72 hours, the CFSE 
dilution was analyzed by FACS.  
(B) Quantification of (A). The values indicate the percentages of the proliferating 
cells. P values were determined by two-tailed Student’s t test (*P < 0.05, 
**P < 0.01, ***P < 0.001).  
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2.4 The role of mitochondria in T-cell activation 
 
Mitochondria have been implicated in T-cell activation, proliferation, cytokine 
production, and AICD, but little is known about the role of mitochondria in human 
primary T cells. Fatty acid catabolism, ATP synthesis, calcium uptake, and ROS 
production are among the mitochondrial processes that have been proposed to 
participate in T-cell functions. Accordingly, the goal of this part of the work was to 
identify the mitochondrial process that plays the key role in T-cell activation. To this 
aim, I have studied the effects of various mitochondrial inhibitors on signaling, 
expression of activation markers, and ROS production in primary human T cells. 
 
2.4.1 Flavin-containing proteins are crucial for T-cell activation 
 
Since the discovery that diphenyleneiodonium (DPI), a flavin-domain inhibitor, is 
able to inhibit phagocytic NADPH oxidase (174), it has been often used to study the 
involvement of NADPH oxidases in various cell processes (175-177). In particular, by 
using DPI, it has been suggested that T cells require NADPH oxidase-generated 
ROS for proper signaling (117). However, in the previous section, I have shown that 
NOX-2 is dispensable for T-cell activation and proliferation. Therefore, I was 
interested to investigate whether DPI can still affect activation of NOX-2-deficient 
mice by other mechanisms. To this aim, I have compared T-cell activation in WT and 
gp91phox-/- mice in the presence of DPI. I have found that DPI strongly affects the 
expression of both CD69 and CD25 activation markers in primary T cells from both 
WT and NOX-2-knockout mice (Fig. 2.10). These data indicate that the effect of DPI 
on T-cell activation is NOX-2-independent. 
DPI is a general inhibitor of flavin-containing proteins, which include but are not 
limited to cytochrome b5 (methemoglobin), methylenetetrahydrofolate, and 
thioredoxin reductases; D-amino acid, monoamine, xantine, and NADPH oxidases; 
Acyl CoA, butyryl CoA, dihydrolipoamide, NADH, and succinate dehydrogenases.  
NADH dehydrogenase (ubiquinone) and succinate dehydrogenase are also 
called mitochondrial electron transport chain (ETC) Complexes I and II, respectively. 
However, it has been shown that DPI selectively inhibits Complex I but not II (178-
181). By blocking Complex I, DPI decreases electron flow through the ETC and 
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hence affects the generation and maintenance of mitochondrial membrane potential 
(MMP) (182). There are two major processes dependent on MMP: mitochondrial ATP 
production (oxidative phosphorylation) and mitochondrial calcium uptake (165, 166). 
The latter is especially important in case of T cells, as it has been shown to be 
necessary for sustained CRAC-mediated calcium influx and NFAT activation in Jurkat 
T cells (159, 160). Therefore, I have hypothesized that DPI may affect T-cell 
activation by disrupting these mitochondrial processes, rather than by blocking NOX-
2-dependent ROS production.  
Indeed, I have found that DPI can dramatically affect primary human T cells. It 
decreases the phosphorylation of Zap70, PLCγ, LAT, and ERK (Fig. 2.11 A) and 
CD69 and CD25 expression (Fig. 2.11 B, C), upon stimulation with CD3xCD28-
coated microbeads. Interestingly, it also decreases the phosphorylation of LCK in 
unstimulated T cells (Fig. 2.12 A), the phosphorylation of MEK and ERK after PMA 
stimulation (Fig. 2.12 B), and general tyrosine phosphorylation after pervanadate 
treatment (Fig. 2.12 C). 
Thus, I have shown that DPI strongly affects activation of primary T cells. Those 
effects could be due to the inhibition of mitochondrial Complex I. However, as DPI 
can potentially target all flavin-containing proteins, which include many metabolic 
enzymes, it is still possible that its effects on T-cell activation are mediated by 
alterations of mitochondria-unrelated processes (183, 184). Therefore, I have 
decided to investigate the effects of the specific mitochondrial Complex I inhibitor 
rotenone on T-cell functions. 
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Figure 2.10 Flavin-containing proteins are crucial for the activation of 
mouse T cells 
(A) Splenic T cells from WT (n=2) or gp91phox-/- (n=3) mice were preincubated with 
DMSO or DPI and stimulated with CD3xCD28-coated microbeads. After 16 
hours, cells were stained with CD25-FITC and CD69-PE mAbs and analyzed 
by FACS. 
(B) Quantification of (A). The values indicate the mean fluorescence intensities. P 
values were determined by two-tailed Student’s t test (*P < 0.05, **P < 0.01, 
***P < 0.001).  
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Figure 2.11 Flavin-containing proteins are crucial for the activation of 
human T cells 
(A) Primary human T cells were preincubated with DMSO or DPI and stimulated 
with CD3xCD28-coated microbeads for 30 min (n=2-4). The ratios of the 
phosphorylated proteins to β-actin were determined by quantifying the band 
intensities on the western blots using ECL, scanner, and ImageQuant 
software. The values indicate the relative protein phosphorylation normalized 
to the stimulated DMSO controls. P values were determined by two-tailed 
Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001).  
(B) Primary human T cells were preincubated with DMSO or DPI and stimulated 
with CD3xCD28-coated microbeads (n=4). After 16 hours, cells were stained 
with CD25-FITC and CD69-PE mAbs and analyzed by FACS. The values 
indicate the mean fluorescence intensities normalized to the stimulated DMSO 
controls. P values were determined by two-tailed Student’s t test (*P < 0.05, 
**P < 0.01, ***P < 0.001). 
(C) Representative dot blots of the data shown in (B).  
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Figure 2.12 Flavin-containing proteins are required for proper TCR 
signaling in primary human T cells 
(A) Primary human T cells were incubated with DMSO or DPI for 30 min (n=3). 
The ratio of phosphorylated LCK to total LCK was determined by quantifying 
the band intensities on the western blots using the Odyssey system. The 
values indicate the relative LCK phosphorylation normalized to the DMSO 
control. P values were determined by two-tailed Student’s t test (*P < 0.05, 
**P < 0.01, ***P < 0.001).  
(B) Primary human T cells were preincubated with DMSO or DPI and stimulated 
with PMA for 30 min (n=2-3). The ratios of the phosphorylated proteins to β-
actin were determined by quantifying the band intensities on the western blots 
using ECL, scanner, and ImageQuant software. The values indicate the 
relative protein phosphorylation normalized to the stimulated DMSO controls. 
P values were determined by two-tailed Student’s t test (*P < 0.05, **P < 0.01, 
***P < 0.001). 
(C) Primary human T cells were preincubated with DMSO or DPI and stimulated 
with pervanadate for 2 min (n=4). The ratio of tyrosine-phosphorylated 
proteins to β-actin was determined by quantifying the band intensities on the 
western blots using ECL, scanner, and ImageQuant software. The values 
indicate the relative protein phosphorylation normalized to the stimulated 
DMSO control. P values were determined by two-tailed Student’s t test 
(*P < 0.05, **P < 0.01, ***P < 0.001).  
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2.4.2 Mitochondrial Complex I is required for T-cell activation 
 
Rotenone inhibits the transfer of electrons from iron-sulfur centers in 
mitochondrial Complex I to ubiquinone (185), thus decreasing electron flow through 
ETC, MMP (186), and hence ATP production and calcium uptake (187). Interestingly, 
rotenone has been shown to inhibit ERK phosphorylation, CD69 expression, 
proliferation, and TNFα production in murine CD8+ T cells (169), CD95L expression 
and AICD in Jurkat T cells and human T-cell blasts (110), as well as IL-2 and IL-4 
production in human T cells (113, 134). 
In agreement with the literature, I have found that rotenone inhibits the 
activation of primary human T cells. It also decreases the phosphorylation of Zap70, 
PLCγ, LAT, and ERK (Fig. 2.13 A) and diminishes CD69 and CD25 expression (Fig. 
2.13 B, C), upon stimulation with CD3xCD28-coated microbeads. Moreover, 
rotenone decreases the phosphorylation of LCK in unstimulated cells (Fig. 2.14 A), 
the phosphorylation of MEK and ERK after PMA stimulation (Fig. 2.14 B), and 
general tyrosine phosphorylation after pervanadate treatment (Fig. 2.14 C). 
Interestingly, rotenone does not have such a dramatic effect on T-cell activation 
as DPI. This confirms my hypothesis that, in addition to Complex I, DPI affects other 
enzymes that are important for T-cell activation. Nevertheless, these data show that 
Complex I activity is required for the activation of primary human T cells. To further 
elucidate the involvement of mitochondria in T-cell activation, I have decided to utilize 
other inhibitors of mitochondrial processes.  
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Figure 2.13 Mitochondrial Complex I is required for the activation of 
human T cells 
(A) Primary human T cells were preincubated with DMSO or rotenone and 
stimulated with CD3xCD28-coated microbeads for 30 min (n=2-4). The ratios 
of the phosphorylated proteins to β-actin were determined by quantifying the 
band intensities on the western blots using ECL, scanner, and ImageQuant 
software. The values indicate the relative protein phosphorylation normalized 
to the stimulated DMSO controls. P values were determined by two-tailed 
Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001).  
(B) Primary human T cells were preincubated with DMSO or rotenone and 
stimulated with CD3xCD28-coated microbeads (n=3). After 16 hours, cells 
were stained with CD25-FITC and CD69-PE mAbs and analyzed by FACS. 
The values indicate the mean fluorescence intensities normalized to the 
stimulated DMSO controls. P values were determined by two-tailed Student’s t 
test (*P < 0.05, **P < 0.01, ***P < 0.001). 
(C) Representative dot blots of the data shown in (B).  
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Figure 2.14 Mitochondrial Complex I is required for proper TCR signaling 
in primary human T cells 
(A) Primary human T cells were incubated with DMSO or rotenone for 30 min 
(n=3). The ratio of phosphorylated LCK to total LCK was determined by 
quantifying the band intensities on western blots using the Odyssey system. 
The values indicate the relative LCK phosphorylation normalized to the DMSO 
control. P values were determined by two-tailed Student’s t test (*P < 0.05, 
**P < 0.01, ***P < 0.001). 
(B) Primary human T cells were preincubated with DMSO or rotenone and 
stimulated with PMA for 30 min (n=2-3). The ratios of the phosphorylated 
proteins to β-actin were determined by quantifying the band intensities on 
western blots using ECL, scanner, and ImageQuant software. The values 
indicate the relative protein phosphorylation normalized to the stimulated 
DMSO controls. P values were determined by two-tailed Student’s t test 
(*P < 0.05, **P < 0.01, ***P < 0.001). 
(C) Primary human T cells were preincubated with DMSO or rotenone and 
stimulated with pervanadate for 2 min (n=4). The ratio of tyrosine-
phosphorylated proteins to β-actin was determined by quantifying the band 
intensities on the western blots using ECL, scanner, and ImageQuant 
software. The values indicate the relative protein phosphorylation normalized 
to the stimulated DMSO control. P values were determined by two-tailed 
Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001). 
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2.4.3 Mitochondria-derived ATP is required for T-cell activation 
 
The inhibitor oligomycin specifically blocks the proton channel (Fo subunit) of 
the mitochondrial ATP synthase (188), thus completely preventing mitochondrial ATP 
synthesis (oxidative phosphorylation). This leads to the increase in MMP (186, 189), 
as protons are not consumed anymore by ATP synthase. However, as MMP is 
maintained and even elevated, MMP-dependent calcium uptake by mitochondria 
should not be blocked by oligomycin. Interestingly, oligomycin was shown to affect 
CRAC calcium currents through ATP depletion (190, 191) or even to directly inhibit 
CRAC in Jurkat T cells, independent of or in addition to its effect on ATP levels (187). 
Oligomycin has been recently shown to block CD25 and CD44 expression and 
proliferation of murine CD4+ T cells (155). 
Consistent with these findings, oligomycin reduces CD69 and CD25 expression 
upon stimulation with CD3xCD28-coated microbeads (Fig. 2.15). Interestingly, it also 
decreases the phosphorylation of LCK in unstimulated cells (Fig. 2.16 A) and general 
tyrosine phosphorylation after pervanadate treatment (Fig. 2.16 B). 
Thus, these data suggest that mitochondrially produced ATP is required for the 
proper activation of primary human T cells. However, the effect of oligomycin on T-
cell activation is weaker than that of rotenone. This could mean that, rather than 
mitochondrial ATP, some other factor, such as MMP, is crucial for proper T-cell 
activation. To address this issue, I have utilized carbonyl cyanide m-chlorophenyl 
hydrazone (CCCP). 
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Figure 2.15 Mitochondria-derived ATP is required for the activation of 
human T cells 
(A) Primary human T cells were preincubated with DMSO or oligomycin and 
stimulated with CD3xCD28-coated microbeads (n=2). After 16 hours, cells 
were stained with CD25-FITC and CD69-PE mAbs and analyzed by FACS. 
The values indicate the mean fluorescence intensities normalized to the 
stimulated DMSO controls. P values were determined by two-tailed Student’s t 
test (*P < 0.05, **P < 0.01, ***P < 0.001). 
(B)    Representative dot blots of the data shown in (A).  
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Figure 2.16 Mitochondria-derived ATP is required for proper TCR 
signaling in primary human T cells 
(A) Primary human T cells were incubated with DMSO or oligomycin for 30 min 
(n=3). The ratio of phosphorylated LCK to total LCK was determined by 
quantifying the band intensities on western blots using the Odyssey system. 
The values indicate the relative LCK phosphorylation normalized to the DMSO 
control. P values were determined by two-tailed Student’s t test (*P < 0.05, 
**P < 0.01, ***P < 0.001). 
(B) Primary human T cells were preincubated with DMSO or oligomycin and 
stimulated with pervanadate for 2 min (n=4). The ratio of tyrosine-
phosphorylated proteins to β-actin was determined by quantifying the band 
intensities on the western blots using ECL, scanner, and ImageQuant 
software. The values indicate the relative protein phosphorylation normalized 
to the stimulated DMSO control. P values were determined by two-tailed 
Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001). 
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2.4.4 Mitochondrial membrane potential is crucial for T-cell activation 
 
CCCP is a mitochondrial uncoupler, which acts as an ionophore, thus allowing 
protons to freely pass through the inner mitochondrial membrane. It disrupts MMP, 
thus preventing ATP synthesis by mitochondrial ATP synthase, as well as calcium 
uptake (113, 159, 160, 189, 192). Interestingly, despite the strong interference with 
mitochondria, CCCP by itself does not induce apoptosis (193-195). CCCP has been 
recently shown to affect IL-2 expression in human CD4+ T cells (113). 
In agreement with these observations, I have found that CCCP strongly affects 
the activation of primary human T cells. It decreases the phosphorylation of Zap70, 
PLCγ, LAT, and ERK (Fig. 2.17 A) and completely abolishes CD69 and CD25 
expression (Fig. 2.17 B, C), upon stimulation with CD3xCD28-coated microbeads. 
Notably, it also decreases the phosphorylation of LCK in unstimulated cells (Fig. 2.18 
A), the phosphorylation of MEK and ERK after PMA stimulation (Fig. 2.18 B), and 
general tyrosine phosphorylation after pervanadate treatment (Fig. 2.18 C).  
Upon comparing the data obtained using rotenone, oligomycin, and CCCP, it 
becomes clear that CCCP exerts much stronger effects on T-cell activation, which 
are especially severe in case of the expression of the activation markers. From these 
data it can be concluded that, in contrast to mitochondria-derived ATP, MMP is 
crucial for primary T-cell activation.  
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Figure 2.17 Mitochondrial membrane potential is crucial for the activation 
of human T cells 
(A) Primary human T cells were preincubated with DMSO or CCCP and 
stimulated with CD3xCD28-coated microbeads for 30 min (n=1-4). The ratio of 
the phosphorylated proteins to β-actin was determined by quantifying the band 
intensities on western blots using ECL, scanner, and ImageQuant software. 
The values indicate the relative protein phosphorylation normalized to the 
stimulated DMSO controls. P values were determined by two-tailed Student’s t 
test (*P < 0.05, **P < 0.01, ***P < 0.001). 
(B) Primary human T cells were preincubated with DMSO or CCCP and 
stimulated with CD3xCD28-coated microbeads (n=2). After 16 hours, cells 
were stained with CD25-FITC and CD69-PE mAbs and analyzed by FACS. 
The values indicate the mean fluorescence intensities normalized to the 
stimulated DMSO controls. P values were determined by two-tailed Student’s t 
test (*P < 0.05, **P < 0.01, ***P < 0.001). 
(C) Representative dot blots of the data shown in (B).  
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Figure 2.18 Mitochondrial membrane potential is required for proper TCR 
signaling in primary human T cells 
(A) Primary human T cells were incubated with DMSO or CCCP for 30 min (n=3). 
The ratio of phosphorylated LCK to total LCK was determined by quantifying 
the band intensities on the western blots using the Odyssey system. The 
values indicate the relative LCK phosphorylation normalized to the DMSO 
control. P values were determined by two-tailed Student’s t test (*P < 0.05, 
**P < 0.01, ***P < 0.001). 
(B) Primary human T cells were preincubated with DMSO or CCCP and 
stimulated with PMA for 30 min (n=2-3). The ratios of the phosphorylated 
proteins to β-actin were determined by quantifying the band intensities on the 
western blots using ECL, scanner, and ImageQuant software. The values 
indicate the relative protein phosphorylation normalized to the stimulated 
DMSO controls. P values were determined by two-tailed Student’s t test 
(*P < 0.05, **P < 0.01, ***P < 0.001). 
(C) Primary human T cells were preincubated with DMSO or CCCP and 
stimulated with pervanadate for 2 min (n=4). The ratio of tyrosine-
phosphorylated proteins to β-actin was determined by quantifying the band 
intensities on western blots using ECL, scanner, and ImageQuant software. 
The values indicate the relative protein phosphorylation normalized to the 
stimulated DMSO control. P values were determined by two-tailed Student’s t 
test (*P < 0.05, **P < 0.01, ***P < 0.001). 
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2.4.5 Mitochondrial ROS production does not correlate with T-cell 
activation 
 
Some studies have shown that mitochondrial ROS are required for the proper 
activation of T cells (134, 143). Therefore, I have hypothesized that the effects of the 
employed mitochondrial inhibitors on T-cell activation might be due to their influence 
on mitochondrial ROS, rather than ATP or MMP levels. To test this hypothesis, I have 
measured ROS levels in primary human T cells in the presence of DPI, rotenone, 
oligomycin, or CCCP (Fig. 2.19 A). DPI, rotenone, and oligomycin strongly induce 
ROS production, whereas CCCP slightly decreases it. On the contrary, all these 
substances inhibit T-cell activation (Fig. 2.19 B, Fig. 2.11 – 2.18). Thus, there is no 
correlation between T-cell activation and the level of mitochondrial ROS. 
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Figure 2.19 Mitochondrial ROS production does not correlate with the 
activation of human T cells 
(A) Primary human T cells were loaded with DCFDA and subsequently treated 
with DMSO or mitochondrial inhibitors for 30 min (n=3). DCFDA fluorescence 
was measured by FACS. The values indicate the increase in the mean 
fluorescence intensity relative to the DMSO control. P values were determined 
by two-tailed Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001). 
(B) Primary human T cells were preincubated with DMSO or mitochondrial 
inhibitors and stimulated with CD3xCD28-coated microbeads (n=2-4). After 16 
hours, cells were stained with CD25-FITC and CD69-PE mAbs and analyzed 
by FACS. The values indicate the inhibition of the mean fluorescence intensity 
relative to the stimulated DMSO control. P values were determined by two-
tailed Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001). 
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3 Discussion 
 
In the first part of this work, I have shown that primary human and mouse T 
cells produce extracellular superoxide via NOX-2 upon the triggering of the TCR. 
However, it appears that this reactive species is not required for T-cell activation, 
proliferation, and cytokine production. To my knowledge, this is the first study 
investigating TCR-induced superoxide production and its functional requirement in 
primary human T cells.  
During the last decades, it has been shown that TCR triggering leads to the 
generation of ROS. However, most of these studies were performed in preactivated T 
cells, such as T-cell blasts or Jurkat T cells. These cells undergo activation-induced 
cell death (AICD) upon restimulation (29), and the produced ROS are mostly involved 
in FasL upregulation. Interestingly, I have not observed any significant superoxide 
production in human T-cell blasts or Jurkat T cells. It has been previously shown that 
some Jurkat T-cell clones do not produce ROS upon stimulation (196), potentially 
due to the heterogeneity of Jurkat T-cell clones in different labs. I have shown that 
superoxide detected using the Diogenes assay was generated by NOX-2 in primary 
T cells (Fig. 2.7). On the other hand, it has been shown that AICD of T-cell blasts is 
not dependent on NOX-2 (119). Thus, it might be that the superoxide detection 
system that I have employed is not sensitive to ROS from other sources, such as 
mitochondria (108, 110, 118) and DUOX-1 (112), which play key roles in AICD. 
Based on ROS measurements using DCFDA, it has been previously suggested 
that also primary human T cells can produce ROS upon CD3 and CD28 stimulations 
(140, 141). However, it is highly plausible that the detected ROS originated from the 
contaminating phagocytic cells, which are often present in preparations of primary T 
cells. Phagocytes can be activated by any antibody via the Fc receptors (138) or by 
direct contacts with activated T cells (83). The selective gating on T lymphocytes 
during the flow-cytometric studies does not help to discriminate the T-cell specific 
ROS from the ROS of phagocytic origin, as the latter is released into the extracellular 
environment, can reach T cells through the medium, and can oxidize a ROS-
sensitive dye within T cells. Moreover, even the dye oxidized inside the phagocytes 
can eventually leak into the medium and can be subsequently taken up by the T 
cells, thus contributing to the increase in their fluorescence. To circumvent these 
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problems, a very high (>99%) purity of the T-cell preparation should be achieved, and 
isotype control antibodies should be used. Unfortunately, these conditions have 
never been fully met. Soluble isotype antibodies were used in one study employing 
primary T cells (140). However, in this study, in-house purified antibodies from an 
ascitic fluid were used for stimulation. It could have happened that non-TCR specific 
antibodies or some other substances present in the ascitic fluid triggered ROS 
production, either in T cells or in phagocytes. Similarly, in another study, a CD3-
containing ascitic fluid was used directly and without controls (141). Additionally, one 
study has shown that CD3 stimulation does not induce DCFDA oxidation in human T 
cells (197). Thus, it is currently not clear whether primary human T cells produce 
ROS upon TCR stimulation, or whether the stimulatory agents trigger non-specific 
ROS production in phagocytes. In my study, I have detected the strong production of 
superoxide (measured using luminol) and ROS in general (measured using DCFDA) 
upon the addition of microbeads coated with isotype control antibodies. These ROS 
most likely originate from phagocytic cells contaminating the preparation. 
Nevertheless, there was a statistically significant increase in luminol (but not DCFDA) 
oxidation in T cells stimulated with CD3xCD28-coated beads as compared to isotype-
coated beads, indicating an additional T-cell-specific superoxide production. A 
possibility that the activated T cells triggered a respiratory burst in the phagocytes by 
the direct cell-cell contact (83) is unlikely due to the rapid initiation of superoxide 
production. Thus, I favor the hypothesis that primary human T cells indeed produce 
ROS, particularly extracellular superoxide, upon TCR triggering. 
One of the most widespread sources of inducible superoxide are NADPH 
oxidases. Importantly, gp91phox, the key component of NOX-2, is expressed in human 
and murine T-cell blasts (116, 119). Interestingly, the same studies have shown that 
gp91phox-/- T-cell blasts are still able to produce superoxide in response to CD3 or 
CD3xCD28 stimulation, similarly to WT T cells. On the contrary, I have observed the 
complete absence of TCR-triggered superoxide production in primary T cells from 
gp91phox-/- mice. This discrepancy is mostly explained by the differences between cell 
types and by superoxide detection methods used. Indeed, the aforementioned 
studies have investigated T-cell blasts that underwent AICD, and superoxide from the 
apoptotic mitochondria (110) was detected by the intracellular DHE (116) or MitoSOX 
(119) dyes. On the other hand, I have investigated primary T cells that were 
physiologically stimulated and have subsequently activated NOX-2 at the plasma 
  
 
86 
membrane (in case of WT mice) or failed to do so (in case of gp91phox-/- mice), and 
superoxide from NOX-2 was detected by the extracellular luminol dye. I have shown 
that, despite the defective superoxide production, gp91phox-/- T cells have the normal 
upregulation of CD25 and CD69 and normal proliferation. This finding supports the 
previous observation that murine CD4+ T cells from gp91phox-/- mice have no defect in 
CD25 expression or IL-2 production (144). However, T cells from that study produced 
less IL-4 and IL-5 but more IL-17 than the WT counterparts (144). This indicates that 
while ROS are not required for T-cell activation, they might be required for T-cell 
differentiation. Interestingly, I have not observed any significant change in cytokine 
production by human CD4+ T cells upon the addition of antioxidants. This 
discrepancy might be explained by differences between human and murine T cells. 
The finding that natural antioxidants do not affect the activation and proliferation 
of primary human T cells appeared initially to be in contrast with some previously 
published data, which show that antioxidants can interfere with CD25 expression 
(150, 151), IL-2 (143, 149) and IL-4 (133) production, and DNA synthesis (150), in 
human and murine T cells. Interestingly, all antioxidants used in these studies – 
NDGA (149, 151), BHA (150, 151), Vitamin E (133), and Mitovitamin E (143) – also 
specifically inhibit lipid peroxidation and/or lipoxygenase activity. SOD, catalase, and 
ascorbate are, on the other side, water-soluble antioxidants that do not interfere with 
lipid peroxidation or lipoxygenase activity. Thus, my results indicate that the reduced 
synthesis of biochemical products of the lipoxygenase pathway – proinflammatory 
molecules leukotrienes, rather than the diminished ROS levels per se, are most likely 
the reason for the previously observed impairment of T-cell activation in the presence 
of the lipid-soluble antioxidants. 
Despite the fact that superoxide is produced upon TCR stimulation, it appears 
to be dispensable for T-cell activation, proliferation, and cytokine production. This 
raises the question: why do T cells need to produce superoxide? An intriguing 
possibility is that extracellularly released superoxide serves as a feedback 
messenger to signal the successful activation to antigen-presenting cells. Indeed, a 
tightly regulated crosstalk between dendritic cells and T cells has been demonstrated 
(92, 198). Further studies investigating T cell-APC interactions in vitro or in vivo are 
required to assess this hypothesis. 
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In addition to NOX-2, other sources of ROS exist in T cells. Mitochondria 
represent one of those. Although in my experimental setup no superoxide was 
detected in the absence of NOX-2, it is still possible that superoxide is produced in 
the mitochondria upon TCR stimulation. In fact, the Diogenes assay measures only 
extracellular superoxide, and DCFDA is not sensitive to superoxide (173). Moreover, 
mitochondria could produce superoxide at late stages of T-cell activation, whereas I 
have focused on early events following TCR triggering.  
In the second part of this study, I have measured ROS levels in primary human 
T cells in the presence of several mitochondrial inhibitors, including DPI, rotenone, 
oligomycin, and CCCP. Interestingly, there is no consistency in the literature about 
effects of DPI on mitochondrial ROS production. DPI has been shown to inhibit ROS 
production at the Complex I of isolated mitochondria during only forward (199), only 
reverse (200), or both forward and reverse electron transport (181), or even to 
increase ROS levels during reverse transport (199). In addition, it has been shown 
that DPI inhibits (201) or induces ROS production in the whole cell (182, 183, 202). It 
seems that the effect of DPI on mitochondrial ROS production depends on the cell 
type and the physiological state of the cells. In my experimental setup, I have 
observed an increase in ROS production in the presence of DPI. Rotenone has been 
shown to induce ROS generation at the level of Complex I during forward electron 
transfer (199, 202-204) but to reduce it during reverse transfer (181). As forward 
electron transport is what is normally observed in cells, my observation that ROS 
production is increased in the presence of rotenone is in agreement with the 
published data. By increasing MMP (186, 189), oligomycin stimulates ROS 
production through the leakage of electrons from the over-reduced respiratory chain 
to oxygen (189, 202, 205). On the contrary, by decreasing MMP, CCCP reduces the 
leakage of electrons from respiratory chain to oxygen and thus reduces mitochondrial 
ROS production (189, 205-207). My data are also in complete agreement with these 
observations. 
Interestingly, I have observed no correlation between T-cell activation and the 
level of ROS in the mitochondria, as both the substances inducing ROS production 
(DPI, oligomycin, rotenone) and the substances decreasing ROS levels (CCCP) had 
an inhibitory effect on T cells. Thus, the question arises whether mitochondrial ROS 
play any role in T-cell activation. It has been shown that mitochondrial ROS are 
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produced during AICD. CD3- and PMAxIono-induced DCFDA oxidation, FasL 
expression, and cell death were all dependent on mitochondrial complex I in Jurkat T 
cells and human T-cell blasts (110). CD3xCD28 stimulation induced MitoSOX 
oxidation and apoptosis in murine T-cell blasts (119). This is consistent with the well-
known role of ROS as executors of apoptosis, but it does not implicate ROS in T-cell 
activation. A recent study suggests that mitochondrial ROS are involved in T-cell 
activation (143). The authors have shown that CD3 and CD3xCD28 stimulations of 
murine CD4+ T cells induce the oxidation of mito-roGFP that is dependent on the 
mitochondrial calcium uptake. They also show that CD3xCD28 and PMAxIono 
stimulations induce the oxidation of MitoSOX that is dependent on the mitochondrial 
Complex III subunit RISP. Finally, they have attempted to show that mitochondrial 
ROS are required for T-cell activation, by studying RISP-deficient T cells. However, 
such a severe defect in the crucial mitochondrial ETC complex necessarily affects 
multiple processes, including the mitochondrial electron transport, respiration, and 
ATP synthesis, besides ROS production. Thus, RISP-deficient cells cannot be used 
to assess the role of mitochondrial ROS in T-cell activation.  
By using mitochondrial inhibitors, I have also shown that mitochondrial 
membrane potential (MMP), but not mitochondria-derived ROS or ATP, is crucial for 
the activation of primary human T cells. Several articles support my hypothesis. 
Murine CD8+ T cells recently activated in vivo by LCMV have the elevated MMP, 
which then decreases during the contraction phase of the immune response (167). 
The mitochondrial biogenesis and MMP increase after the stimulation of murine T 
cells (168). Interestingly, in human CD4+ T cells the MMP drops immediately after 
stimulation, but is required for IL-2 expression (113). MMP is required for calcium 
buffering by mitochondria (165, 166). Mitochondrial calcium uptake, in turn, is 
necessary for sustained CRAC-mediated calcium influx and NFAT activation in T 
cells (113, 159, 160). 
In summary, in this work I have shown for the first time that primary T cells 
produce extracellular superoxide via NOX-2 upon the TCR stimulation, and that 
mitochondrial membrane potential, but not NOX-2 or mitochondria-derived ROS or 
ATP, is crucial for T-cell activation. 
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4 Materials and methods 
 
4.1 Cell isolation and culture 
 
4.1.1 Ethics 
 
Approval for these studies, involving the analysis of TCR-mediated signaling in 
human T cells, was obtained from the Ethics Committee of the Medical Faculty at the 
Otto-von-Guericke University, Magdeburg, Germany, with the permission number 
[107/09]. Informed consent was obtained in writing in accordance with the 
Declaration of Helsinki. All experiments involving mice were performed according to 
the guidelines of the State of Sachsen-Anhalt, Germany. 
 
4.1.2 Human T-cell purification and culture 
 
PBMCs were isolated by the Ficoll gradient (Biochrom AG) centrifugation of 
heparinized blood collected from healthy volunteers. T cells were further purified by 
non-T-cell depletion using human pan T-cell isolation kit and AutoMACS (all from 
Miltenyi Biotec). The purity of T cells, determined by FACS, was routinely more than 
96%. T cells were cultured at 106 cells/ml, 37°C, and 5% CO2 in RPMI 1640 medium 
supplemented with stable glutamine (Biochrom AG), 10% fetal calf serum (PAN 
Biotech), and 2 µg/ml ciprobay (Bayer). 
 
4.1.3 Murine T-cell purification and culture 
 
gp91phox-/- mice were a kind gift from Dr. Katrin Breitbach (Friedrich Loeffler 
Institute of Medical Microbiology, Ernst-Moritz-Arndt University, Greifswald, 
Germany). WT control C57BL/6JBom mice were obtained from Taconics. Mice were 
kept in pathogen-free conditions. In order to obtain a single-cell suspension, spleens 
from mice were passed through a fine mesh filter (BD Falcon). T cells were purified 
by non-T-cell depletion using the mouse pan T-cell isolation kit and AutoMACS (all 
from Miltenyi Biotec). The purity of T cells, determined by FACS, was routinely more 
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than 96%. The cells were cultured at 106 cells/ml, 37°C, and 5% CO2 in RPMI 1640 
medium supplemented with stable glutamine (Biochrom AG), 10% fetal calf serum 
PAN Biotech), 2 µg/ml ciprobay (Bayer), and 50 μM β-mercaptoethanol (Sigma 
Aldrich). 
 
4.1.4 Jurkat T-cell culture 
 
Jurkat T cells were maintained at 1-3x105 cells/ml, 37°C, and 5% CO2 in RPMI 
1640 medium supplemented with stable glutamine (Biochrom AG), 10% fetal calf 
serum (PAN Biotech), 100 U/ml penicillin (Biochrom AG), and 100 µg/ml 
streptomycin (Biochrom AG). 
 
4.1.5 Human T-cell blast generation and culture 
 
Purified human T cells were stimulated with 1 nM PMA and 200 ng/ml 
ionomycin (both from Sigma-Aldrich) and cultured at 37°C and 5% CO2 in RPMI 1640 
medium supplemented with stable glutamine (Biochrom AG), 10% fetal calf serum 
(PAN Biotech), and 2 µg/ml ciprobay (Bayer). After 2 days medium was replaced, 
and 100 U/ml interleukin 2 (PeproTech) was added. Cells were cultured for additional 
24 hours before performing experiments. 
 
4.2 Antioxidants and inhibitors 
 
The following antioxidants or inhibitors were purchased from Sigma-Aldrich and 
used at the indicated concentrations: superoxide dismutase (SOD) from bovine 
erythrocytes at 100 U/ml, catalase from Corynebacterium glutamicum at 1000 U/ml, 
L-ascorbic acid (ascorbate) at 100 µM, L-glutathione reduced at 500 µM, 
diphenyleneiodonium chloride (DPI) at 10 μM, rotenone at 5 μM, oligomycin from 
Streptomyces diastatochromogenes at 1 μM, carbonyl cyanide 3-
chlorophenylhydrazone (CCCP) at 10 μM. Cells were preincubated with the 
compounds at 37°C for 30 min before stimulation and kept in the presence of the 
compounds for the whole duration of the experiment. SOD, catalase, ascorbate, and 
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glutathione were freshly diluted in PBS. DPI, rotenone, oligomycin, and CCCP were 
diluted in DMSO and stored at -20°C. Appropriate solvent was used in the negative 
control samples. 
 
4.3 Cell stimulation 
 
4.3.1 Microbead stimulation 
 
Cells were stimulated with immobilized CD3xCD28 mAbs as previously 
indicated (170). Briefly, SuperAvidin™-coated polystyrene microspheres (Bangs 
laboratories, Inc., Ø~10 µm, binding capacity: 0.02-0.04 µg biotin/mg) were coated 
with biotinylated CD3 (clone UCHT1, mouse, IgG1) and CD28 (clone CD28.2, 
mouse, IgG1) mAbs (10 µg/ml each, BioLegend) for 30 min at 37°C in PBS 
Dulbecco (Biochrom AG). Antibody-coated microspheres were washed three times, 
resuspended in PBS at 108 beads/ml, and incubated with cells in a 1 bead per cell 
ratio. Microspheres coated with 20 µg/ml biotinylated mouse IgG1 (eBioscience) 
were used as the isotype control. 
Mouse cells were stimulated with CD3 (clone 145-2C11, hamster, IgG1) and 
CD28 (clone 37.51, hamster, IgG2λ1) mAbs (10 µg/ml each, both from BD 
Pharmingen) immobilized on microspheres as described above. Microspheres coated 
with biotinylated hamster IgG1 and IgG2λ1 (10 µg/ml each, both from BD 
Pharmingen) were used as the isotype control. 
 
4.3.2 PMA stimulation 
 
Cells were incubated with 1 nM phorbol 12-myristate 13-acetate (PMA, Sigma-
Aldrich). 
 
4.3.3 Pervanadate stimulation 
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Cells were incubated with the 1:100 dilution of freshly prepared pervanadate 
mixture (10 mM sodium orthovanadate and 3% hydrogen peroxide, both from Sigma-
Aldrich). 
 
4.4 Detection of ROS 
 
4.4.1 General oxidation assay 
 
For general ROS detection, 2’,7’-dichlorofluorescin diacetate (DCFDA, 
Invitrogen) was used. Cells were centrifuged, resuspended at the density of 107 
cells/ml in a prewarmed serum-free phenol red-free RPMI 1640 medium (Gibco) 
containing 2 µM of DCFDA, aliquoted to microcentrifuge tubes (100 µl suspension 
per tube), placed on a thermoshaker (37°C, 300 rpm), and incubated for 30 min. 
Then cells were stimulated with microbeads for 30 min, diluted 1:5 in ice-cold PBS 
Dulbecco (Biochrom AG), and immediately analyzed by flow cytometry using 
FACSCalibur with CellQuest software or LSRFortessa with FACSDiva Software 6.1.3 
(all from BD Biosciences) for data acquisition and FlowJo 7.5.5 (Tree Star, Inc.) for 
data analysis. During the measurement procedure, cells were protected from bright 
light. 
 
4.4.2 Superoxide assay 
 
For superoxide detection, the Diogenes Cellular Luminescence Enhancement 
System (National Diagnostics) was used according to the manufacturer’s instructions. 
Briefly, cells were centrifuged, resuspended at the density of 107 cells/ml in a pre-
warmed serum-free phenol red-free medium RPMI 1640 (Gibco), and placed into 
black polystyrene flat bottom 96-well plate (Costar, Corning Inc., 100 µl suspension 
per well). Diogenes Reagent and Diogenes Activator were freshly mixed in a 1:9 ratio 
and added to the samples (50 µl per well). Subsequently, T cells were stimulated with 
microbeads, and luminescence was repeatedly measured with 5 min intervals for the 
total of 60 min using TriStar LB941 multimode reader (Berthold technologies). Cells 
were kept at 37°C. 
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4.5 Western blotting 
 
4.5.1 General procedure 
 
T cells were centrifuged, resuspended in a serum-free RPMI 1640 medium 
(Biochrom AG) at the density of 107 cells/ml, aliquoted to microcentrifuge tubes (100 
µl suspension per tube), placed on a thermoshaker (37°C, 300 rpm), and stimulated 
as described above. At indicated time points, reactions were terminated by adding 1 
ml of ice-cold PBS Dulbecco (Biochrom AG) per sample. Cells were immediately 
centrifuged, and pellets were lysed in 30 µl of ice-cold buffer containing 1% Igepal 
CA-630 (Sigma-Aldrich), 1% lauryl maltoside (Calbiochem), 50 mM 
tris(hydroxymethyl)-aminomethane (pH 7.5), 150 mM NaCl, 10 mM 
ethylenediaminetetraacetic acid (all from Carl Roth GmbH), 10 mM NaF, 1 mM 
Na3VO4, and 1 mM phenylmethanesulfonyl fluoride (all from Sigma-Aldrich, see 
Appendix for detailed buffer recipes) for 20 min. Subsequently, cell nuclei were 
pelleted by 10 min centrifugation at 13000 x g at 4°C. Supernatants were transferred 
to new microcentrifuge tubes containing 7.5 μl of 5x reducing sample buffer, mixed, 
and heated on a thermoshaker (100°C, 600 rpm) for 5 min. Lysates were separated 
by SDS-PAGE system (Bio-Rad) and transferred using a semi-dry Western blotting 
system (Bio-Rad) onto nitrocellulose membranes (Amersham Biosciences).  
 
4.5.2 Chemiluminescent detection 
 
Membranes were immunoblotted using the indicated primary antibodies and the 
appropriate horseradish peroxidase-conjugated secondary antibodies (Dianova) and 
developed using the enhanced chemiluminescence detection system and X-ray film 
(both from Amersham GE Healthcare). The following primary antibodies were used 
for Western blotting in this study: anti-pY493 ZAP-70, anti-pY171 LAT, anti-pY783 
PLCγ-1, anti-pS217/221 MEK-1/2, anti-pT202/Y204 ERK-1/2 (all from Cell Signaling 
Technology), anti-phosphotyrosine horseradish peroxidase conjugate (clone 4G10, 
Millipore), and anti-β-actin (clone AC-15, Sigma-Aldrich). For data analysis, film 
images were acquired using the Epson V700 scanner, and intensities of the detected 
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bands were quantified using the Kodak 1D ImageQuant software. Band intensities 
from phosphorylated proteins were normalized to band intensities from β-actin, 
before the further processing of the data. 
 
4.5.3 Fluorescent detection 
 
Membranes were incubated with primary rabbit anti-pY416 Src antibody (Cell 
Signaling Technology) and secondary anti-rabbit antibody labeled with IRDye 680LT 
(LI-COR Biosciences) and scanned with Odyssey Classic infrared imager (LI-COR 
Biosciences) in 700 nm channel. Subsequently, membranes were incubated with 
primary mouse anti-LCK antibody (clone 28/LCK, BD Biosciences) and secondary 
anti-mouse antibody labeled with IRDye 800CW (LI-COR Biosciences) and scanned 
in 800 nm channel. Images were acquired and quantified using the LI-COR Image 
Studio 2.1.15 software. Signal from phospho-LCK (lower /p56/ band of pSrc staining) 
was normalized to signal from total LCK, before the further processing of the data. 
 
4.6 Cellular assays 
 
4.6.1 Activation assay 
 
T cells were seeded to flat bottom polystyrene 48-well plates (Costar, Corning 
Inc.) at 106 cells/ml in the volume of 500 µl per well and stimulated with microbeads. 
After 16 h, cells were stained with FITC- or PE-labeled mAbs against CD25 and 
CD69 (BD Pharmingen, BioLegend) and analyzed by flow cytometry using 
FACSCalibur with CellQuest software or LSRFortessa with FACSDiva Software 6.1.3 
(all from BD Biosciences) for data acquisition and FlowJo 7.5.5 (Tree Star, Inc.) for 
data analysis. Microbeads and cell debris were always excluded from the analysis. 
 
4.6.2 Proliferation assay 
 
T cells were centrifuged, resuspended in 1 ml of PBS Dulbecco (Biochrom AG), 
and labeled with 2.5 µM CFSE (Invitrogen) for 15 min at 37°C. Then cells were 
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washed twice, resuspended in medium at the density of 106 cells/ml, seeded to flat 
bottom polystyrene 48-well plates (Costar, Corning Inc.) in the volume of 500 µl per 
well, and stimulated with microbeads. Cells were cultured for 72 h, and proliferation 
was assessed by CFSE dilution using FACSCalibur with CellQuest software or 
LSRFortessa with FACSDiva Software 6.1.3 (all from BD Biosciences) for data 
acquisition and FlowJo 7.5.5 (Tree Star, Inc.) for data analysis. Microbeads and cell 
debris were always excluded from the analysis. 
 
4.6.3 Cytokine assay 
 
Human CD4+ Tnai cells were purified from PBMCs by non-T-cell depletion using 
human CD4+ Tnai-cell isolation kit and AutoMACS (both from Miltenyi Biotec). T cells 
were resuspended in serum-free X-VIVO 15 medium supplemented with gentamycin 
(Lonza), seeded to flat bottom polystyrene 48-well plates (Costar, Corning Inc.) at 106 
cells/ml in the volume of 1 ml per well, and stimulated with microbeads. After 48 h of 
incubation, supernatants were harvested, supplemented with 0.5% bovine serum 
albumin (Sigma-Aldrich), and frozen at -80°C. Later, cytokine concentrations in the 
supernatants were measured simultaneously using the Bio-Plex Pro assay on the 
Bio-Plex 200 system (Bio-Rad) according to the manufacturer’s protocol. The Bio-
Plex Manager software was used for acquisition and analysis. 
 
4.7 Data visualisation and statistical analysis 
 
The graphical visualization and statistical analysis of the data were performed 
using GraphPad Prism 5 (GraphPad Software, Inc.). Bars and dots on the graphs 
indicate the mean of values measured in several (n) independent experiments, while 
error bars indicate the standard error of the mean (SEM). Significance was calculated 
by two-tailed Student's t test (* 0.01<P≤0.05, ** 0.001<P≤0.01, *** 0<P≤0.001). No 
asterisk indicates that the difference was not statistically significant. 
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Western blotting recipes 
 
Lysis buffer (1 ml) 
657 µl ddH2O 
100 µl 10% Igepal CA-630 (Sigma-Aldrich) 
100 µl of 10% lauryl maltoside (Calbiochem) 
50 µl 1M tris(hydroxymethyl)-aminomethane, pH 7.5 (Carl Roth GmbH) 
33 µl 5M NaCl (Carl Roth GmbH) 
20 µl 0.5M ethylenediaminetetraacetic acid, pH 7.5 (Carl Roth GmbH) 
20 µl 0.5M NaF (Sigma-Aldrich) 
10 µl 0.1M Na3VO4 (Sigma-Aldrich) 
10 µl 0.1M phenylmethanesulfonyl fluoride (Sigma-Aldrich) 
 
5x reducing sample buffer (10 ml) 
5 ml glycerol (Sigma-Aldrich) 
2.5 ml 20 % sodium dodecyl sulfate (Calbiochem) 
2 ml 0.5 M tris(hydroxymethyl)-aminomethane, pH 6.8 (Carl Roth GmbH) 
250 µl 10% bromphenol blue (Carl Roth GmbH) 
500 µl β-mercaptoethanol (Sigma-Aldrich) 
 
SDS-PAGE resolving gel (10%, 10 ml) 
4 ml ddH2O  
3.4 ml acrylamid 30% (Bio-Rad) 
2.6 ml 1.5 M tris(hydroxymethyl)-aminomethane pH 8.8 (Carl Roth GmbH)  
100 µl 10% sodium dodecyl sulfate (Calbiochem)  
100 µl 10% ammonium persulfate (Carl Roth GmbH)  
10 µl tetramethylethylenediamine (Carl Roth GmbH) 
 
SDS-PAGE stacking gel (5%, 3.3 ml) 
1.9 ml ddH2O  
0.6 ml 30% acrylamid (Bio-Rad) 
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0.8 ml 0,5M tris(hydroxymethyl)-aminomethane, pH 6.8 (Carl Roth GmbH)  
33 µl 10% sodium dodecyl sulfate (Calbiochem) 
33 µl 10% ammonium persulfate (Carl Roth GmbH)  
3.3 µl tetramethylethylenediamine (Carl Roth GmbH) 
 
Transfer buffer (1 l) 
800 ml dH2O 
5.8 g tris(hydroxymethyl)-aminomethane, pH 6.8 (Carl Roth GmbH) 
2.93 g glycine (Carl Roth GmbH) 
3.75 ml 10% sodium dodecyl sulfate (Calbiochem) 
200 ml methanol (Carl Roth GmbH) 
 
10x TBS buffer (1 l) 
1000 ml dH2O 
80 g NaCl (Carl Roth GmbH) 
30 g tris(hydroxymethyl)-aminomethane pH 8 (Carl Roth GmbH) 
2 g KCl (Sigma-Aldrich) 
 
Washing buffer (1 l) 
900 ml dH2O 
100 ml of 10x TBS 
1 ml of Tween 20 
 
Blocking/Antibody buffer (100 ml) 
100 ml of Washing buffer 
5 g of milk powder/bovine serum albumin 
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